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Abstract 
Burkholderia pseudomallei is a soil-dwelling saprophyte and the cause of 
melioidosis. Multilocus sequence typing (MLST) of 266 Thai B. pseudomallei isolates 
(83 soil and 183 invasive) defined 123 sequence types (STs). Invasive isolates were 
over-represented in the 10 largest clones, and there was a significant difference in the 
classification index between environmental and disease isolates, confirming that 
genotypes were not distributed randomly between the two samples. MLST profiles for 
158 predominantly invasive isolates from northern Australia contained a similar 
number of STs (96) as the Thai invasive isolates, but no ST was found in both 
populations. This analysis revealed strong genetic differentiation on the basis of 
geographical isolation, and a significant differentiation on the basis of virulence 
potential. 
The presence and distribution of five genomic islands described for B. 
pseudomallei K96243 was investigated in natural populations. In silico analysis of 10 
B. pseudomallei genome sequences demonstrated variable presence of these regions, 
together with evidence for micro-evolutionary changes that generates GI diversity. 
Their presence was assessed in environmental (83) and invasive (103) B. 
pseudomallei isolates using PCR. Positivity ranged from 12% for a prophage-like 
island (GI 9), to 76% for a metabolic island (GI 16). The presence of each of the five 
GIs did not differ between environmental and disease-associated isolates. There was 
no reproducible association between the individual or cumulative presence of five GIs 
and clinical features in 103 patients with melioidosis. 
Burkholderia thailandensis is a non-pathogenic soil saprophyte which is 
highly related to B. pseudomallei. MLST of a collection of B. thailandensis isolates 
demonstrated two clusters. One cluster contained three isolates (one each from 
xv' 
France, the U. S. and Cambodia), and the second larger cluster contained isolates from 
Thailand, Vietnam and Laos. eBURST analysis indicated that the larger cluster 
formed a single clonal complex, while all three strains of the small cluster were 
singletons. 
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Chapter 1. Introduction 
1.1 General background to Burkholderiapseudomallei 
1.1.1 Historical aspects 
Burkholderia pseudomallei is the cause of a serious human infection termed 
melioidosis. This organism was originally described in 1912 by Whitmore and 
Krishnaswami who were working as pathologists in Rangoon, Burma (now Yangon, 
Myanmar)264 The term "melioidosis" was introduced in 1921 by Stanton and Fletcher 
to describe a disease of horses that was similar to, but not the same as glanders (which 
is caused by the highly related Burkholderia mallei). This word is derived from 
Greek; 'melis' means a distemper of asses and 'eidos' means resembles glanders. 
Melioidosis is clinically and pathologically similar to glanders, but the ecology and 
epidemiology of melioidosis are markedly different. B. pseudomallei is now regarded 
as a major tropical pathogen, 262 and has been classified by the United States Centers 
for Disease Control as a category B biothreat agent. 199 This organism is classified as 
a biological hazard group 3 agent in Europe and many other countries of the world 
and must be handled in BSL3 containment facilities. 
1.1.2 Classification and description 
B. pseudomallei has been given a variety of names including Bacillus 
pseudomallei, Bacillus whitmorii, Pfeifferella whitmorii, Actinobacillus pseudomallei, 
Loefferella whitmorii, Malleomyces pseudomallei, Pfeifferella pseudomallei and 
Pseudomonas pseudomallei. In 1973, it was grouped within the genus Pseudomonas 
as a Pseudomonas RNA homology group 11.174 In 1992, members of this group were 
transferred to the new genus, Burkholderia, based on 16S rRNA sequence, DNA- 
1 
DNA homology, cellular lipid and fatty acid composition and phenotypic 
characteristics. 276 
B. mallei, the causative agent of glanders, and B. thailandensis, a normally 
non-virulent organism, are genetically closely related to B. pseudomallei. These 
species can be differentiated from B. pseudomallei by the characteristics of motility 
and arabinose assimilation. B. mallei is non-motile due to its inability to express 
flagella, 132 compared with B. pseudomallei and B. thailandensis which are motile. B. 
thailandensis assimilates arabinose while B. pseudomallei and B. mallei do not. 
Arabinose utilization is determined by growth on minimal salt agar containing 0.2% 
L-arabinose 215 Both B. pseudomallei and B. mallei have a deleted operon encoding 
arabinose fermentation. 162 
B. pseudomallei is a small (- 0.6 x3 µm) motile, Gram-negative bacterium. It 
is non-spore forming, oxidase-positive and grows aerobically but can survive under 
anaerobic conditions in the presence of nitrate or arginine276 Optimum temperature 
for growth of B. pseudomallei in vitro is 37 - 420C; the organism is unable to grow at 
temperatures less than 21IC. 18° However, some strains appear to be able to survive for 
prolonged periods (greater than 190 days) at 50C under laboratory conditions? " B. 
pseudomallei is positive for catalase and indophenoloxidase. The bacterium usually 
exhibits bipolar staining (likened to a safety pin) on Gram stain because of 
intracellular deposits of ß-hydroxybutyric acid. The accumulation of prominent 
granules of ß-hydroxybutyric acid as an energy store reflects a metabolism adapted to 
long-term survival. 104 B. pseudomallei in clinical specimens may not have bipolar 
staining, and may rarely be observed on Gram stain as long filaments. 
The colony appearance of B. pseudomallei on solid agar differs depending on 
the medium used. On blood agar the colonies are smooth and shiny. Ashdown's 
2 
selective medium is commonly used to isolate the organism from clinical specimens 
containing mixed flora. This medium contains gentamicin, crystal violet and 
glycerol. 16 The typical colony morphology after 48 hours or more of incubation in air 
at 370C is a wrinkled, purple colony which has been likened to a cornflower head 
(Figure 1.1). Less common morphologies have been described on Ashdown's agar, 33 
including a smooth colony type. Colonies growing on agar are described as having an 
earthy odour, although sniffing of plates is prohibited for safety reasons. In vitro 
subculture on ferric citrate-containing medium leads to alteration in colony 
morphology on Ashdown's agar. It can change into either a larger, glistening, mucoid, 
dark purple colony type or a smaller, flat, light purple colony type. 5° 
When B. pseudomallei is grown in broth culture, a dry pellicle with a matt 
surface often forms. 224 This pellicle forms at the broth-air interface, possibly because 
of positive aerotaxis of B. pseudomallei. 
3 
Figure 1.1 B. pseudomallei in culture (reproduced from262) 
Left: B. pseudomallei growing on Ashdown's selective medium. Right: the organism 
forming a surface pellicle in broth. 
4 
B. pseudomallei is intrinsically resistant to many antibiotics, including first, 
second and third-generation cephalosporins, aminoglycosides, penicillins and 
polymyxin. '7,39"54'237 The organism is usually susceptible to ceftazidime, the 
carbapenem antibiotics, amoxicillin-clavulanate, piperacillin-tazobactam, doxycycline 
and trimethoprim-sulfamethoxazole (TMP-SMX). 108 Carbapenem antibiotics have the 
greatest activity in vitro, while fluoroquinolones have poor activity in vitro. 67'218 Rare 
clinical isolates are susceptible to gentamicin and macrolides, occurring in the order 
of approximately I in every 1000 isolates. 213 The beta-lactams and ciprofloxacin are 
bactericidal in vitro, whereas the agents conventionally used to treat melioidosis 
during the oral phase of treatment (doxycycline and TMP-SMX) have bacteriostatic 
activity only. 67 A detailed summary of in vitro activities of antibiotics against B. 
pseudomallei can be found in a review by Cheng and Currie, 2005.39 
B. pseudomallei is inherently resistant to ampicillin and broad- and expanded- 
spectrum cephalosporins due to the production of a beta-lactamase. Phenotypic 
characterization of the beta-lactamase produced by B. pseudomallei has shown it to be 
a weakly inducible, membrane associated chromosomal cephalosporinase which is 
strongly active against carbenicillin, cefotaxime and cefuroxime, and inactivated by 
clavulanic acid. '45 Sequence analysis of the beta-lactamase gene penA (or blaA; 
Ambler class A) revealed conserved motifs typical of class A beta-lactamases and a 
relationship to penA (in B. cepacia) and blal (in Yersinia enterocolitica) lineages 47 
Macrolide and aminoglycoside resistance is mediated via a multidrug efflux pump., 61 
The genome of B. pseudomallei strain K96243 (originating from Thailand) has 
been sequenced and comprises two chromosomes of 4.07 Mb and 3.17 Mb. 104 The 
large chromosome carries many genes associated with core functions such as cell 
growth and metabolism, while the smaller chromosome carries more genes encoding 
5 
accessory functions that could be associated with adaptation and survival in different 
environments. Around 6% of the genome is made up of putative genomic islands that 
have probably been acquired via horizontal gene transfer. These are mostly absent 
from the B. thailandensis genome (and are absent from the B. mallei genome); it is 
unclear whether these regions have a role in disease pathogenesis. The Institute of 
Genomic Research (Rockville, MD, USA) is currently sequencing nine further B. 
pseudomallei isolates and 25 B. pseudomallei bacteriophage genomes originating 
from various sources. In addition, sequencing of the B. thailandensis (strain E264) 
genome is now completed (www. tigr. org)4 and published. 
128 
1.2 B. pseudomallei in the environment 
B. pseudomallei is a saprophytic organism which can be found in soil or 
surface water across much of southeast Asia and Northern Australia. Variables that 
may affected the distribution of the organism in soil include climatic factors such as 
temperature, pH, moisture (rainfall), sunlight (UV), and soil composition (physical, 
chemical and biological). ' '7 Well-drained, light, sandy soils are less able to support 
the prolonged persistence of B. pseudomallei than waterlogged, heavy clay soils. 111 
Water content in soil has been reported to determine the duration of B. pseudomallei 
survival in the laboratory. This bacterium was able to survive for 70 days if the water 
content in soil was less than 10%, and was prolonged to 726 days if there was more 
than 40% water content. , 273 
In melioidosis-endemic regions, environmental conditions have been shown to 
play a role in growth and persistence of B. pseudomallei in soil. It was reported that a 
higher B. pseudomallei count was present in superficial clay soil compared to deeper 
samples during the rainy season. 240 However, the overall isolation rate was higher 
6 
during the dry season than during the wet season. This could be the result of better 
aeration of soi1272 The organism can resist drying, since B. pseudomallei can be 
cultured from dry soil 4 weeks after inoculation in the laboratory, provided suitable 
resuscitation methods using serial subculture on 5% horse blood agar were used in the 
initial stages of bacterial isolation. 115 B. pseudomallei has also been reported to 
survive in water at room temperature for up to 8 weeks, in muddy water for up to 7 
months, in soil in laboratory conditions for up to 30 months239 and in sterile triple- 
distilled water without any addition of nutrients for more than 3 years. 273 
Wet rice fields have been reported to reach a temperature of 40-430C , 
229 a 
temperature that is permissive for B. pseudomallei growth. Soil temperature is 
usually greater in cleared land than in forested areas, which might account for the 
greater yield of B. pseudomallei in rice fields. 163,217 Evidence for persistence in the 
soil within non-tropical climates includes survival of B. pseudomallei for several 
years in the environment during the French outbreak in the 1970's. '60 This affected a 
zoo in the Jardin des Plantes, equestrian clubs, and human contacts associated with 
extensive environmental contamination 64 
pH is another factor that can influence the survival of B. pseudomallei. The 
organism can be isolated from soil and water at a wide range of pH (2.0 - 9.0), 
84 but 
the optimum pH range for B. pseudomallei has been reported to be between pH 5 and 
8. Under laboratory conditions, a pH below 4.5 has been reported to lead to rapid 
bacterial inactivation which may represent a viable but non-culturable form. 244 The 
soil from which B. pseudomallei was most commonly isolated in the highly endemic 
region of Thailand was reported to be acidic. 123 The survival of B. pseudomallei may 
be favored by the relatively acidic environment of rice paddy fields, which are pH 
4.4-7.7 in northeast Thailand. 123 It has also been reported that B. pseudomallei was 
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more acid tolerant and adaptable to starvation than Burkholderia cepacia and 
Pseudomonas aeruginosa under laboratory conditions 
7° 
Other factors that may effect the survival of this organism are aeration and UV 
exposure. During the rainy season, in Thailand the isolation rate increased with 
increasing depth, but remained uniform between 30 - 60 cm depth during the dry 
season. 272 The mean B. pseudomallei count from soil sampled from Northeast 
Thailand was 20-fold higher than that from Central of Thailand217 In Australia, one 
study reported that samples from clay soils collected at 25 - 45 cm depth were most 
likely to be positive and surface soil was rarely culture positive. 
40 B. pseudomallei 
could be found in clay at depths of 120 cm. 9 Tong et al (1996)244 reported that under 
laboratory conditions, B. pseudomallei was more easily killed by UV light than other 
soil bacteria. However, at present, there is little evidence to suggest that B. 
pseudomallei is significantly different from other bacterial species in the ability to 
resist UV light or repair the damage that UV light induces. 117 The effect of osmotic 
stress has been examined using variable sodium chloride (NaCI) concentrations. B. 
pseudomallei can survive in NaCI at less than 2.5% wt/vol. 106 Little is known about 
survival of this organism in sea water! 17 
Survival of B. pseudomallei following internalization into amoebic cysts has 
been reported. ' 16 Persistence in amoebic cysts may represent a means of surviving 
stressful environmental conditions, although this has not yet been proven in the 
natural environment. Amoebic species in which B. pseudomallei can survive include 
Acanthamoeba astronyxis, Acanthamoeba castellanii, Acanthamoeba palestiniensis 
and Acanthamoeba polyphaga. 116 There are several similarities between B. 
pseudomallei and Legionella spp., both of which are environmental saprophytes 
capable of intracellular parasitism. B. pseudomallei employs the coiling phagocytosis 
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mechanism to penetrate free-living amoeba. Bacillus-filled amoebic vacuole size is 
close to that of aerosolized particles that can enter the human respiratory tract. As in 
the case of Legionella, the infective particle for melioidosis and the normal 
intracellular habitat may be the same entity 28 It is known that virulence of Legionella 
is enhanced on amoebic passage, 53 but this has not been studied for B. pseudomallei. 
Additional putative environments for B. pseudomallei are reported to be the 
cytoplasm of arbuscular mycorrhizal fungi, legumes (nitrogen-fixing plants) and other 
plants such as rice, rubber and cassava. 116,141,163,175,234 It had been proposed that B. 
pseudomallei can reduce nitrate in order to grow in an anaerobic environment in 
association with legumes, and the use of nitrate fertilizers might thus contribute to its 
proliferation in agricultural land. These relationships with other organisms may not 
only play an important role in bacterial survival, but in potential ecological niches and 
the distribution of B. pseudomallei. 
1.3 Geographical distribution of B. pseudomallei 
1.3.1 Global epidemiology 
B. pseudomallei is present in the environment between latitudes 20°N and 
20°S of tropical or sub-tropical climates. South East Asia and northern Australia are 
notable endemic areas for melioidosis. Most reported cases of melioidosis are 
associated with agricultural occupations (particularly rice farming in Thailand), or 
other activities leading to exposure to soil and water. The numbers of cases in 
endemic areas are highest during the rainy season. In non-endemic areas, cases of 
melioidosis involve infection in returning travelers and in transported animals. The 
worldwide distribution of melioidosis as it is currently understood is summarized in 
Figure 1.2. 
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Figure 1.2 Worldwide distribution of melioidosis (reproduce from 39) 
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1.3.1.1 Australia - Pacific region 
The first report of human melioidosis within this region involved a diabetic 
patient in Townsville in 1950,54°197 one year after an outbreak in sheep in Winton, 
Northern Queensland. 54 Most reported cases in Australia occur in the northern 
territories. B. pseudomallei has since been isolated from the environment in Northern 
Australia, including paddocks, moist soil and mud, vegetable matter and water 
reservoirs. 29°61'111,239,240 
Other regions outside of northern Australia including the southwest, central 
and eastern regions have also reported indigenous melioidosis. 57'91,209 Infection has 
also occurred in relation to a contaminated drinking supply and pipes in Western and 
Northern Australia. 63,113,114 Serosurveys of populations throughout Australia that 
defined the presence of antibodies to B. pseudomallei have demonstrated that 
seropositivity in the Northern Territory is higher than Queensland, 59 a finding that is 
consistent with disease incidence. 
Papua New Guinea (PNG), particularly the western region, has been reported 
to be a melioidosis endemic region 59'261 The first case report of melioidosis was in a 
serviceman stationed in PNG during World War 11.129 Thereafter, a small number of 
human cases and first bacterial isolation (from a tree climbing kangaroo)76 were 
documented from Port Moresby, Central PNG 55,134,200 A series of confirmed cases of 
melioidosis have been described in Balimo, Western PNG. 260 Two small serological 
studies failed to detect antibody to B. pseudomallei, 22,2°° but a larger serological study 
conducted in Balimo reported that the seroprevalence and estimate annual incidence 
rate (6.2 - 10.4% and 20 per 100,000) were similar to the Northern Territory of 
Australia (5 - 13% and 16.5 - 34.5 per 100,000). 59,261 
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Six cases of melioidosis have been diagnosed between 1999 and 2004 in New 
Caledonia, which is located in Oceania, east of Queensland, Australia. All were from 
the Northern Province. Molecular typing of two of the associated isolates suggested a 
link to an Australian strain. '33 
1.3.1.2 Asia 
Thailand: Thailand is considered to be the world epicentre of melioidosis, reporting 
more than 1,000 cases each year from the northeast of the country alone. Yet the first 
case in an indigenous Thai patient was not described until 1955,50 and the second 
report only appeared in 1974.176 Since then there has been rapid economic 
development, and microbiology facilities in provincial hospitals have improved 
considerably. By 1985, Thai investigators were able to review a detailed clinical 
experience of over 800 cases of melioidosis. 138 This illustrates how closely the 
apparent epidemiology of melioidosis (and many other tropical infections) is linked 
with the availability of microbiology facilities and trained personnel 241 Melioidosis is 
now recognized as the most common cause of severe community-acquired 
bacteraemia in northeast Thailand where it accounts for 20% of cases and 40% of 
sepsis-related deaths. 36 The calculated incidence rate in northeast Thailand of 
4.4/100,000232 is likely to be a significant underestimate because of continued 
ascertainment difficulty59°262 Around three quarters of cases present during the rainy 
season, with a strong association with rainfall. 32 
PDR Laos: The first ever introduction of a blood culture system at Mahosot Hospital 
in Vientiane, the capital of Lao PDR, has led to the description of a significant burden 
of disease from melioidosis. 179 B. pseudomallei has also been isolated from soil taken 
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from areas surrounding the capital city272 The number of melioidosis cases in other 
areas of Laos is currently unknown. 
Vietnam: This country came under the spotlight as a region endemic for melioidosis 
during WWII and then during the conflict with the US. Between 1965 until the 
withdrawal of U. S. forces in 1972, the Melioidosis registry of the United State Army 
Office of the Surgeon-General (OTSG-MR) received reports of 343 cases, with 15 
deaths, 205 and a further 21 deaths for which melioidosis was a contributor. Serological 
studies indicated that between 25,000 and 225,000 army personnel were exposed. 130 
A significant proportion of the infections reported by the military presented were sub- 
acute or chronic pulmonary infections (10% of the cases in American soldiers were 
misdiagnosed initially as pulmonary tuberculosis). 58 In some the latency between 
exposure and disease was months or years (the disease has been labelled the 
"Vietnamese time-bomb"). 223 A soil survey has demonstrated the presence of B. 
pseudomallei in soil sampled around Ho Chi Minh City. 175 
Singapore, Malaysia and Indonesia: Melioidosis has been recognized as an 
important human infectious disease in Singapore since the 1990's. 101,185,186 The first 
reported case occurred in 1989. The estimated annual incidence in Singapore is 1.7 
per 100,000 population. 101 
In Malaysia in the early 1910s, melioidosis caused an outbreak among 
laboratory animals in the Institute for Medical Research of the Federated Malay 
States227 Seven patients were diagnosed with acute septicaemic melioidosis in Kuala 
Lumpur between 1976 to 1979,184 and another 10 cases were diagnosed between 1981 
and 1986282 Melioidosis became increasingly recognised thereafter, with a reported 
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85 cases from both Peninsular and east Malaysia, and 50 cases from Kuala Lumpur. 
185 
A total of 135 cases diagnosed between 2000 and 2003 were reported from Pahang, of 
whom 54% died. 105 
Indonesia is likely to be endemic for melioidosis, although reported cases are 
limited to infection in returning travelers to Australia, United Kingdom and United 
State S, 69,92,207 and to cases that occurred in the aftermath of the tsunami of 2004 
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China, Hong Kong and Taiwan: Melioidosis was first reported in Taiwan in 1984, 
in which a previously healthy patient presented with multilobar pneumonia after near 
drowning in the Philippines. 136 Several cases have since been described, together with 
an outbreak . 
23,108,137,1 46 Forty cases were reported after a typhoon in 2005. This 
confirms that melioidosis is endemic to Taiwan. 131 
Small numbers of cases have been reported in Hong Kong since 
1983,220,221,248,267 while infection in marine mammals in the Hong Kong occanarium is 
an on-going problem. 102 In China, 4.2% of environmental soil and water samples were 
reported to be positive for B. pseudomallei. 279 Seroprevalence in Southern China's 
Hainan Island ranges from 8.8 to 66.7%, with the highest antibody titers found in 
farmers in areas of Xinglong280 A seropositivity rate of 34% has also been reported 
among rice farmers, 278 but the incidence of melioidosis is currently unknown. 
Other parts of Asia: Occasional patients have been reported from India, Sri Lanka, 
Guam, and the Philippines 65,118,119 
14 
1.3.1.3 Areas outside Asia 
Sporadic case reports have been documented in Central and South America, 
West and East Africa, Europe and the Caribbean, encompassing such widely 
divergent areas as Brazil, Panama, Mexico, Puerto Rico, Ecuador and other countries 
of northern South America. 52,66,159 B. pseudomallei has also been reported in Northern 
America (California). 3 Cases of melioidosis have been reported from Turkey, Iran, 
Madagascar, Kenya, Central West Africa, South Africa and Europe, 65 but these were 
predominantly in citizens or ex-servicemen who had returned home after traveling 
within or emigrating from an endemic area. 
1.4 B. pseudomallei infection 
1.4.1 Melioidosis in animals 
B. pseudomallei has an extremely broad host range. Among domestic animals, 
melioidosis is most commonly reported in sheep, goats and swine. Sporadic cases 
have been reported in a range of other animals including the monkey, gibbon, orang- 
utan, kangaroo, wallaby, deer, buffalo, cow, camel, llama, zebra, koala, dog, cat, 
horse, mule, parrot, certain bird species, rat, hamster, rabbit, guinea pig, ground 
squirrel, snake, fish, seal, dolphin and crocodile. 224 
Outbreaks affecting animals have been reported to occur following 
importation from endemic areas. Fournier (1965)86 considered that this accounted for 
the introduction of melioidosis into Aruba, and also into Australia after World War II. 
The gift of an infected panda from China, the so called "Affaire du Jardin des Plantes" 
may have precipitated an outbreak in France in 1975.160 Infection subsequently spread 
to other zoos in Paris and Mulhouse and throughout France, and led to the death or 
slaughter of an unknown number of animals. 2 An outbreak in the United Kingdom 
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has also been reported to have occurred in primates imported from the Philippines and 
Indonesia. 68 
Studies in animal models have been performed including inbred mouse strains, 
hamsters, chickens, rats and guinea pigs. 
54,255,263 BALB/c mice represent the most 
common animal model used for the study of B. pseudomallei virulence 
250 
1.4.2 Human melioidosis 
1.4.2.1 Risk factors 
In northeast Thailand, Suputtamongkol et al., 1994232 noted that 81% of cases 
of melioidosis occurred in rice farmers or their families. In northern Australia, 72.5% 
of patients with melioidosis were reported to be male, and 49% were Aborigines who 
have a lifestyle involving frequent exposure to tropical soils and surface water 
through daily activities and hunting. 2 Merianos et al. (1993)155 and Suputtamongkol 
et al. (1999)231 reported that the risk of melioidosis was approximately 10-fold higher 
in those with heavy occupational soil exposure compared with indoor workers, and in 
Aborigines irrespective of their employment. 
Underlying conditions such as diabetes mellitus, renal failure or dysfunction 
and alcoholism are important risk factors for melioidosis 
34,62,138,214 Diabetes mellitus 
is the most commonly recognized risk factor for melioidosis in the major melioidosis- 
endemic countries including Thailand, 
36,231 Malaysia, 185 Singapore and 
Australia. 60'138'231 In Thailand, the rate of diabetes mellitus in melioidosis cases is 
reported to be 60%231 Renal disease is present in 20-27% of melioidosis patients in 
Thailand, 36,231 respectively) compared with 9% in northern Australia. 62 Malignancy, 
chronic lung disease, connective tissue disease and steroid therapy are additional risk 
factors. Chronic lung disease may be important in circumstances involving infection 
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following inhalation of B. pseudomallei. 58 Alcoholism is a documented risk factor. In 
Thailand, 12% of melioidosis cases had a history of heavy alcohol consumption, 23' 
compared with 37% in northern Australia. 62 Alcohol excess appears to be less 
common as a risk factor in Malaysia185 and Singapore. This may reflect the 
differences in alcohol consumption by different populations. Studies using animal 
models show that acute alcohol intoxication results in significant immune 
dysfunction. 284 Other risk factors include thalassemia, which is present 7% in Thai 
patients, iron overload and tuberculosis, although their roles as independent risk 
factors are yet to be confirmed231 HIV does not appear to be a risk factor for 
melioidosis 49 
A study of risk factors in northern Australia showed that the absence of risk 
factors predicted for survival, and that the only individual risk factor associated with 
mortality was chronic renal disease. The higher mortality rate in those with renal 
diaease was associated with a higher rate of bacteraemia (85%). 62 
1.4.2.2 Disease acquisition and incubation period 
Melioidosis is limited to individuals exposed to environments containing B. 
pseudomallei. Acquisition of melioidosis may occur via three major routes, i. e. 
inhalation, ingestion and inoculation. Contamination of existing wounds or new 
penetrating wounds with B. pseudomallei present in soil and water is likely to 
represent the major route of infection in farmers in northeast Thailand. 232 Evidence for 
inhalation as a route of infection comes from cases of melioidosis in US soldiers 
involved in the war with Vietnam, when helicopter crews and servicemen were 
infected after inhalation of particles created by helicopters. 107,201,206 Melioidosis may 
follow aspiration of contaminated water during near drowning, ' 83,232 and occurred 
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following near drowning in several people involved in the tsunami of December 
2004 20 An outbreak associated with contaminated drinking water' 12 indicates that 
ingestion is an additional possible route, although this is probably rare. Other possible 
modes of infection include laboratory accidents. 
Melioidosis is seasonal in the tropics where most cases occur during the rainy 
season. This can be explained by increased contact with the organism. Rice farmers 
plant at the start of the monsoon and work in flooded rice paddies until harvest. Thai 
farmers rarely wear protective footwear and their feet often show signs of repeated 
trauma and injuries. Extreme weather may be associated with a shift in the mode of 
acquisition of infection. Aerosols are created during heavy rain, and this may result in 
repeated inhalation of the organism. Heavy rainfall and winds consistently result in a 
shift towards more pneumonia in patients presenting with melioidosis in Northern 
Australia. 61 Severe or penetrating injury and near-drowning are known risk factors for 
melioidosis, as highlighted by a study of a cluster of melioidosis cases in Southern 
Thailand following the 2004 tsunami. 8 
Limited person-to-person transmission of B. pseudomallei has been reported. 
Transmission may occur in utero, and melioidosis in two infants in Northern Australia 
was related to breast-feeding by mothers with mastitis caused by B. pseudomallei. '°'181 
The wife of a Vietnam veteran with chronic prostatitis caused by B. pseudomallei was 
shown to have developed an antibody response to the organism in the absence of 
clinical manifestations of melioidosis. 188 Person-to-person transmission may have 
occurred between a diabetic brother and sister living in endemic northeast Thailand, 37 
and between 2 siblings with cystic fibrosis. 6 Nosocomial melioidosis from a 
suspected environmental source has been reported from an endemic area35, but cross 
infection between hospital in-patients has not been reported. Vector-borne 
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transmission via mosquito (Aedes agypti) and rat flea (Xenopsylla cheopsis) has been 
described. 167 
The period between B. pseudomallei exposure and onset of clinical 
manifestations is highly variable and often difficult to define. In one study, only 25% 
of cases reported a specific inoculation event from which an incubation period of 1-21 
days (mean 9 days) was derived. 59 Aspiration may be associated with a large bacterial 
inoculum, and the incubation period may be very short. 49 The incubation period may 
also be very prolonged, 51"52 the maximum recorded being 62 years. 166 Factors that 
provoke the reactivation of latent B. pseudomallei in vivo include stress and reduced 
immunity. 120,24' 
The time from onset of disease to clinical presentation is highly variable, 
reflecting the broad range in disease severity. In Northern Australia, 13% of patients 
presenting for the first time had symptoms for more than two months. 59 In the 
Wellcome Unit Melioid Lab in Ubon Ratchathani, northeast Thailand, around a third 
of patients had symptoms for less than 7 days, one half report being unwell for 7-28 
days and the remainder had symptoms for more than 28 days. 270 
1.4.2.3 Clinical features 
Manifestations of disease are extremely broad ranging. Melioidosis has been 
called the great mimicker because of its protean clinical features. 82 These range from 
asymptomatic seroconversion, acute fulminant infection and chronic disease which 
can mimic tuberculosis or malignancy. 247,262 A common clinical picture is that of a 
septicemic illness, often associated with bacterial dissemination to distant sites such 
that concomitant pneumonia and hepatic and splenic abscesses are common. 
Pneumonia occurs in around 50% of patients. Infection may also occur in bone, joints, 
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skin (superficial pustules and cutaneous abscesses), soft tissue (pyomyositis) and 
prostate 59,185,262 A specific syndrome of meningoencephalitis with flaccid paraparesis 
or peripheral motor weakness occurs in 4% of cases in Northern Australia '60 and 
cerebral abscess is well described. 1 Involvement of the vascular tree is recognized but 
unusual. Acute parotitis accounts for one third of childhood cases in Thailand, 
67,262 
but is unusual in Thai adults and is rarely seen in any age group outside of Thailand. 
1.4.2.4 Diagnosis 
Isolation and identification of the organism represents the diagnostic gold 
standard. B. pseudomallei is not thought to exist as a member of the normal flora. 
This is based on studies of the presence of the organism on throat swab taken from 
patients with or without melioidosis. In one study, 36% of 1,011 patients with 
melioidosis were throat swab positive compared with none of 3,524 healthy subjects 
or patients with other diseases. 274 In a second study, 8 of 17 children with melioidosis 
were throat swab positive, but no swabs were positive for 1000 children admitted to 
the same ward with other conditions. 124 Patients admitted to Sappasithiprasong 
Hospital in Ubon Ratchathani hospital over the last 20 years who were culture 
positive for B. pseudomallei invariably have features consistent with melioidosis (S. 
Peacock, personnal communication). Individuals in endemic areas with contaminated 
wounds but no signs or symptoms of infection have not undergone systematic study, 
and the possibility of wound colonization in the absence of disease has not been 
excluded. Several cases reported to ProMED following the tsunami of 2004 were 
culture positive for B. pseudomallei but did not have symptoms consistent with 
melioidosis. Full clinical information for these cases has not been published to date. In 
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the meantime, it is prudent to suspect melioidosis in anyone with a positive culture 
from any site, and to investigate accordingly. 
1.4.2.4.1 Bacterial identification 
Samples of blood, urine and respiratory secretions should be obtained for 
culture from all patients, together with pus and wound swabs where relevant. Early 
discussion with senior members of the clinical microbiology laboratory is important 
during investigation of suspected cases. This will raise awareness for the presence of a 
significant pathogen in a mixed culture. Furthermore, B. pseudomallei is classified as 
a hazard group 3 biological agent and should be cultured using the appropriate 
containment level. ASM have produced sentinel laboratory guidelines for suspected 
Burkholderia mallei and B. pseudomallei. These are useful reference documents for 
laboratories that are not familiar with culture and identification of B. pseudomallei 2 
Samples of pus, respiratory secretions, urine and throat swab are plated 
directly onto non-selective (blood agar) and selective media (MacConkey agar and 
Ashdown's medium). If Ashdown's medium is not available, B. cepacia medium is a 
good alternative. 87 Additional steps can be taken to increase the yield of positive B. 
pseudomallei cultures from most samples, as follows. Urine should be plated neat, 
then spun (3000rpm for 5 min) and the entire pellet plated. Quantitative count of B. 
pseudomallei does not appear to have the same significance in terms of defining 
urinary tract sepsis, and bacteria in urine are likely to reflect systemic disease rather 
than isolated urinary sepsis. 142 In view of this, even a single colony in urine should be 
interpreted as clinically significant. Yield from pus samples will be improved if a 48- 
hour enrichment step in liquid medium such as TSB is used. Yield from respiratory 
secretions, throat and wound swabs that contain mixed flora will be enhanced by 48 
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hours pre-incubation in a selective liquid medium. 109 All media are incubated at 370C 
in air. Colonies are usually visible on agar after 24 hours incubation, but may be very 
small on selective media. All plates should be re-examined after 48 hours incubation. 
Additional information can be derived from blood culture. Time to blood 
culture positivity has prognostic significance, with a mortality rate of 73.7% for those 
with a positive culture within 24 hours compared with 40.9% in patients with blood 
cultures positive after 24 hours 242 The quantitative count of B. pseudomallei is related 
to outcome; around one quarter of 108 patients examined in northeast Thailand had 
>100 colony forming units (cfu)/mL blood. Counts of <1 cfu/mL were associated 
with a mortality of 42%, compared with a mortality of 96% in those with counts of > 
100 cfu/mL257 
Bacterial colonies on Ashdown's medium are usually purple, dry and wrinkled 
(`cornflower head') after 48 hours incubation. Gram stain shows Gram-negative rods; 
bipolar (safety pin) staining has been described, but this is variably present and not 
unique to this species. The organism is motile, indole negative, oxidase positive, and 
resistant to colistin and gentamicin, features that aid identification 85 Laboratories in 
endemic settings describe the use of direct immunofluorescent microscopy and latex 
agglutination methodology for rapid bacterial identification, 12,182,216,236 but these are 
in-house reagents and are not widely available. Commercial biochemical profile kits 
such as API20NE have been shown to be highly reliable for identification of strains in 
Thailand, 67'258 but a recent study of isolates from a diverse geographical area 
demonstrated a much lower accuracy (60%). 89 If commercial kits do not identify a 
suspected B. pseudomallei isolate, then confirmatory identification can be carried out 
by a reference laboratory using standard biochemical testing and/or PCR 
amplification and sequencing. Use of conventional and real-time PCR to identify B. 
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pseudomallei direct from blood or from bacterial colonies has been described, 170'230 
but this is not part of current routine identification strategies. Susceptibility testing to 
ceftazidime, imipenem or meropenem, co-amoxiclav, doxycycline and trimethoprim- 
sulfamethoxazole should be performed using relevant guidelines. Susceptibility to 
trimethoprim-sulfamethoxazole should be assessed using one of the established MIC 
methods; E-test is reliable and easy to perform. 
1.4.2.4.2 Serology 
Most healthy individuals (>80%) living in northeast Thailand show evidence 
of seroconversion during childhood (indirect hemagglutination (IHA) titre of 
>1: 10), 38'124 and some healthy individuals have very high titres (? 1: 160), but the 
overwhelming majority will not present with melioidosis during their lifetime. Thus 
serology has low diagnostic utility in melioidosis-endemic regions. Interpretation of 
serology in the non-endemic setting requires knowledge of travel history and place of 
normal residence. Paired sera demonstrating a rising antibody titre to B. pseudomallei 
taken from an individual who does not normally reside in an endemic area supports 
the diagnosis of melioidosis in the presence of clinical features of disease. 
Seroconversion in an asymptomatic individual implies exposure, but it is unclear 
whether one should automatically infer that the patient is either actively infected, or 
will present with melioidosis after a variable incubation period. 
A range of serological tests has been evaluated, most of which are not 
commercially available and have not been validated in the non-endemic setting. The 
IHA test has been studied extensively in endemic areas where it is clear that 
background seropositivity results in poor test specificity when used for diagnostic 
purposes. 127,169 Increasing the IHA cut-off leads to a rise in specificity, but a 
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predictable loss in sensitivity. 15 Evaluation of the IHA in Singapore (where disease is 
sporadic) indicates that this test is more useful in the low endemic or non-endemic 
setting. '°", 28' Using a cut-off titre of 1: 16, less than 1% of the asymptomatic 
population had a positive titre, while all 20 patients tested with melioidiosis had titres 
of 1: 16 or greater. 101,281 The diagnostic cut-off used to define a positive result varies 
between studies; > 1: 10 has been used to define seroconversion in Thailan d38,124 and 
titres of > 1: 16,1: 40 and 1: 160 have all been used to define a reactive or diagnostic 
titre. '°"235,281 
Several other serological tests have been described, including an indirect 
immunofluorescent assay (IFA), 19"'51,252 enzyme-linked immunosorbent assay 
(ELISA) using culture filtrate or affinity purified antigen, 19'45,211,211,266 and dot 
immunoassay. 11,266 Data are not available on their utility and performance compared 
with IHA in non-endemic areas. An immunochromatographic test kit has been 
developed for the rapid detection of IgG and IgM antibodies to B. pseudomallei, and 
this has been evaluated in Thailand and Australia. ' 72,268 Based on results for IgG, this 
kit represents an alternative to the IHA but has not been released onto the market. 
1.4.2.4.3 Molecular diagnostics 
Real-time PCR has been developed for the rapid detection of B. pseudomallei 
DNA, including assays that target genes encoding 16S rRNA, flagellin (F1iC), 
ribosomal protein subunit S21 (rpsU), 243 type III secretion systems (TTS1 and 
TTS2 , 
156, »0,238 and two sequences unique to B. pseudomallei designated 8653 and 
943 8.230 A prospective clinical evaluation conducted in Darwin, Australia of a real- 
time PCR assay targeting the TTS1 type III secretion system gene cluster included 33 
individuals with culture-confirmed melioidosis; sensitivity and specificity for patient 
24 
diagnosis were 91% and 95%, respectively. '56 A retrospective study evaluated the 
real-time PCR targets 8653 and 9438, using samples collected in northeast Thailand 
from 28 patients with culture-confirmed melioidosis and 17 patients with bacteremia 
caused by other pathogens. The sensitivity was 71% and 54% for 8653 and 9438 
respectively, and specificity was 82% and 88%, respectively. 30 These findings 
suggest that detection of B. pseudomallei in clinical samples using molecular 
approaches may have utility for the early diagnosis of melioidosis. 
1.4.2.5 Treatment 
Appropriate antimicrobial agents should be commenced immediately on 
suspicion of the diagnosis of melioidosis. Ideally, culture should be performed prior to 
administration of antibiotics but treatment should not be delayed if culture cannot be 
performed rapidly, as in the case of aspiration of pus under imaging or operative 
intervention. Collections of pus should be drained where feasible (including operative 
washout for infected joints). Patients with severe melioidosis associated with septic 
shock, respiratory failure associated with severe infection or adult respiratory distress 
syndrome, acute renal failure, and other manifestations of a severe septic illness 
require intensive care management where this is available. The availability of ICU in 
different geographical regions is an important contributor to the marked difference in 
outcome between Australia and Thailand. A predictive scoring system for outcome 
has been devised based on age at diagnosis, presence of pneumonia, serum urea, 
serum bilirubin, lymphocyte count, and serum bicarbonate. 1A number was assigned 
from 0 to 2 based on the degree of abnormality and a score formed from the sum. A 
score of <3 was associated with a mortality of 8.6%, while >4 was associated with a 
mortality of 44.6%. APACHE II score is an independent predictor of mortality in 
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mclioidosis, and has the advantage of being a routine part of intensive care 
management. 
Routine laboratory tests arc useful to detect the onset of acute renal failure, 
abnormal liver function tests and anemia, all of which are well recognized during 
severe mclioidosis. Arterial blood gases should be taken in patients with. lung 
involvement and/or any evidence of respiratory impairment. One small study 
indicated that serial serum C-rcactivc protein levels aid patient management; CRP in 
five culture-positive patients with complicated disease remained elevated until the 
infection was brought under control. 18 However, a recent review of CRP in 175 
patients found that admission CRP may be normal or only mildly elevated, including 
patients with severe sepsis, fatal cases, and in relapsed mclioidosis. 43 
Chest radiographs should be taken in all patients with suspected mclioidosis. 
Common radiographic patterns include localized patchy alveolar infiltrate, focal, 
multifocal or lobar consolidation, diffuse interstitial shadowing considered consistent 
with blood borne spread of infection, pleural effusion, and upper-lobe involvement 
which may include cavitation. ' "-262 The radiographic pattern may mimic tuberculosis. 
The development of cmpycma and/or lung abscess arc well recognized, and repeat 
chest radiographs may be clinically indicated for patients with respiratory 
involvement. Abdominal ultrasound or CT scan should be performed to exclude the 
presence of abscesses in liver and spleen. Clinical evidence of prostatic involvement 
requires appropriate imaging (trans-rectal ultrasound or CT scan). " The need for 
other imaging will depend on clinical features and organ involvement. 
Fever clearance is often slow, (median fever clearance time of 9 days), and 
without evidence of clinical deterioration is not normally sufficient to indicate the 
need for a change in therapy. 262 Sputum and draining abscess cultures may remain 
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positive for several weeks in a patient who is otherwise responding to treatment. A 
patient who has clinical deterioration or persistently positive blood cultures should be 
viewed as failing treatment, at which stage the need for imaging, drainage of 
collections and change in antimicrobial therapy should be considered. 
Treatment recommendations are based on clinical evidence, supported by a 
Cochrane review published in 2001 and updated in 2002203,204 Treatment is required 
to complete 12-20 weeks, or longer if clinical indicated. This is divided into 
intravenous and oral phases. There are some differences in treatment protocols 
developed at Sappasithiprasong Hospital, Ubon Ratchathani, Thailand, and the Royal 
Darwin Hospital, Australia. 
Initial parenteral therapy is given for 10-14 days or until clinical response is 
seen (which ever is the longer). Ceftazidime or a carbapenem antibiotic is the 
treatment of choice. Ceftazidime is used as first line therapy in Thailand, with a 
switch to a carbapenem antibiotic in the event of treatment failure on ceftazidime. In 
Thailand, intravenous amoxicillin-clavulanate is used to treat children and pregnant 
women and is second line empiric treatment for adults, but this preparation is not 
available in Australia. Parenteral treatment at the Royal Darwin Hospital consists of 
ceftazidime, or meropenem plus Granulocyte colony-stimulating factor (G-CSF) if 
the patient has septic shock. 39 The routine addition of TMP-SMX to ceftazidime or 
meropenem during the initial intensive therapy phase has recently been discontinued 
in Darwin, 56 although this drug is still used to treat patients with neurological or 
prostatic melioidosis in view of its excellent penetration into CSF and prostate. 56 
Oral treatment to complete 12-20 weeks of therapy consists of TMP-SMX 
alone (Australia) or together with doxycycline (adults in Thailand). First-line oral 
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treatment for pregnant women and children is amoxicillin-clavulanate; this is also an 
alternative for adults who cannot tolerate TMP-SMX. 
G-CSF was adopted for use in patients with septic shock due to melioidosis at 
the Royal Darwin Hospital, northern Australia in December 1998. This was 
associated with a decrease in mortality from 95% to 10%. Risk factors, the duration 
of illness before presentation, and the severity of illness were similar in patients 
before and after G-CSF introduction, but improvements in intensive care management 
also occurred during the study period. A randomized placebo-controlled trial of G- 
CSF for severe melioidosis has been completed at Sappasithiprasong Hospital, 
northeast Thailand 42 This was not shown to improve outcome. A placebo-controlled 
trial of an intravenous PAF receptor antagonist (lexipafant) in 131 adult Thai patients 
with suspected severe sepsis included 36 patients with melioidosis; no benefit was 
detected. 233 Other interventions shown to be of benefit in critically ill septic patients 
such as goal-directed therapy, ' 98 intensive glycemic control253 and activated protein 
C24 have not been evaluated in patients with melioidosis. 
1.4.2.6 Relapse 
Disease relapse is common; recurrent infection occurred in 13% of survivors 
over 10 years in Northern Australia, with a mean time from initial diagnosis to 
recurrence of 8 months. 60 This mirrors recurrence rates in Thailand. 262 Choice and 
duration of oral antimicrobial therapy are the most important determinants of relapse, 
followed by positive blood culture (HR 1.86; 95%CI, 1.18-2.92) and multifocal 
distribution (HR 1.95; 95%CI, 1.03-3.67). Patients treated with an appropriate oral 
antibiotic regimen for 12 to 16 weeks have a 90% decreased risk of relapse (HR 0.10; 
95%CI, 0.02-0.44) compared with patients treated for S8 weeks. Three quarters of 
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recurrent cases are due to relapse, the remainder representing re-infection by a 
different strain. 147 Culture and susceptibility testing of the causative isolate is central 
to further management. Bacterial genotyping is now a necessity for treatment trials 
that use recurrence rates as an outcome measure, allowing treatment failure to be 
distinguished from re-infection. 
1.4.2.7 Prevention 
Exposure to B. pseudomallei is very difficult to prevent, especially in rice- 
farming areas and occupational-related soil exposure. Persons with diabetes and skin 
lesions should avoid contact with soil and standing water in endemic areas. Protective 
clothing such as rubber boots and gloves during agricultural work can prevent 
infection through the feet and hands. 
There is no effective vaccine available that protects against B. pseudomallei 
infection. Current approaches under evaluation include conjugate-, DNA-, attenuated- 
and hetcrologous vaccines. 259 Attenuated mutants that are invasive but have a reduced 
ability to multiply in phagocytes have been identified using transposon mutagenesis, 
and these induce a high degree of protective immunity in mice. 265 A mutant of B. 
pseudomallei that is auxotrophic for branched-chain amino acids induced a protective 
response against a subsequent challenge with an otherwise lethal dose of wild-type B. 
pseudomallei in an animal model. 21 Mice inoculated with a B. pseudomallei bipD 
mutant were partially protected against subsequent challenge with wild-type B. 
pseudomallei, although immunization with purified BipD protein was not 
protective. 228 However, it seems unlikely that live attenuated vaccination will be 
feasible for use in humans. Antibodies raised against B. pseudomallei flagellin 
markedly reduced bacterial motility and provided passive protection against 
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experimentally induced B. pseudomallei infection. 7 Evaluation of LPS and capsular 
polysaccharide as subunit vaccines against experimental melioidosis demonstrated 
partial protection in a mouse model. 164 Guinea pig inoculation with B. thailandensis 
provided partial protection from a subsequent challenge with virulent B. 
pseudomallei. 11o 
It was recently postulated that the T-cell response to primary B. pseudomallei 
infection is biphasic, with an early cytokine - most notably IFNy - induced phase in 
which T cells appear to be functionally redundant for initial bacterial clearance, 
followed by a later antigen-induced phase in which B. pseudomallei-specific T-cells - 
in particular CD4+ T-cells are important for host resistance. 77 In view of the fact that 
B. pseudomallei infection generates a rapid and potent IFNy response from NK T- and 
conventional T cells, it is has been suggested that an effective subunit vaccine against 
B. pseudomallei should target the generation of IFNy-secreting T cells. 98 This was 
further underscored by a recent report suggesting that any potential vaccine would 
need to stimulate both cell-mediated and humoral immunity. 1°° In this study, dendritic 
cells were utilized as a vaccine delivery vector to induce cell-mediated immune 
responses to B. pseudomallei. Purified dendritic cells were pulsed with heat-killed 
whole-cell B. pseudomallei and used to immunize syngeneic mice. Strong cellular 
immune responses were elicited, although antibody responses were low. 
Subsequently, booster immunizations of either a second dose of dendritic cells or 
heat-killed B. pseudomallei were administered to increase the immune response. 
Immunized animals were challenged with fully virulent B. pseudomallei, and 
protection was demonstrated in those with both a strong humoral and cell-mediated 
immunity. '00 The possible utility of these observations for vaccine development 
awaits further investigation. 
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1.5 Horizontal Gene Transfer 
The significance of horizontal gene transfer between bacteria was first 
recognized in the 1950's with the emergence of multi-drug resistance. The ability of 
different bacteria to develop resistance to the same spectrum of antibiotics suggested 
that these traits were being transfer between species. Horizontal or lateral gene 
transfer has since been recognized as the basis for genetic variability and phenotypic 
plasticity for many bacterial species, and represents a mechanism by which bacteria 
can evolve and adapt to new environments. 94 Unlike vertical gene transfer which 
occurs between organisms during reproduction, horizontal gene transfer occurs in the 
absence of reproduction. A significant proportion of bacterial genetic diversity can be 
attributed to the acquisition of sequences from other organisms, contrasting with 
eukaryotes which evolve principally through the modification of existing genetic 
information. 
1.5.1 Identification of horizontal gene transfer in bacterial genomes 
DNA sequence information has been used to define features that indicate 
horizontal gene transfer. For example, DNA segments gained through horizontal gene 
transfer may display a restricted phylogenetic distribution among related species. In 
addition, these regions may show small levels of DNA or protein sequence similarity 
that is absent from closely related organisms. 173 Another important marker of gene 
acquisition is the G+C content. The average G+C content of a given bacterial species 
can be calculated, allowing variation from the average to be determined. Such regions 
will highlight gene acquisition from species with a different G+C content, but will fail 
to recognize transfer between species with similar G+C contents. In the latter case, 
31 
more subtle markers such as base composition, frequency and patterns of codon usage 
can be determined. A different approach used is to search for genes with functions 
that are often associated with horizontal gene transfer, such as mobility genes, 
integrases, transposases or phage-related genes. 
1.5.2 Genomic islands 
Genomic islands are regions of DNA of variable length (between 10 to 200 
kilobases) that are acquired through horizontal gene transfer. 125 These regions often 
differ from the recipient genome with respect to G+C content and codon usage. 
Genomic islands commonly contain genes associated with mobilization, and are often 
located adjacent to tRNA genes (phage attachment sites) and/or insertion sequence 
(IS) elements. Directed repeats (DR), which are defined as DNA sequences of 16 to 
45 bp with a perfect or nearly perfect sequence repetition, frequently flank the 
genomic islands. Islands may demonstrate a mosaic structure, a reflection of repeated 
integration events. 93 
Genomic islands first came to prominence when it became clear that they 
could carry genes that were involved in disease pathogenesis; these were termed 
`pathogenicity islands'. However, islands that appear to contribute to other aspects of 
bacterial existence such as fitness in the environment due to the presence of genes 
encoding metabolic functions have since been described. The division of fitness 
islands into different subtypes is not based on their intrinsic genetic composition, but 
on their effects in a specific niche and within a particular organism. In other words, 
the same fitness island may act as an ecological island when the bacterial recipient 
resides outside of a host, but become a pathogenicity island when the bacterium enters 
a host. 
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1.5.3 Mechanisms of horizontal gene transfer 
Horizontal gene transfer occurs between the same or related species. The 
prerequisites for this process are that: (i) there is a means by which donor DNA can be 
delivered into the recipient cell; (ii) the acquired sequences must be incorporated into 
the recipient's genome or into an autonomous replicating element such as plasmid; 
and (iii) the incorporated genes must be expressed in a manner that is appropriate to 
the recipient environment. 75 The third step depends on compatibility between the 
transferred genes and the transcriptional and translational machinery of the host 
organism. The known mechanisms by which horizontal gene transfer occurs are 
transformation, transduction and conjugation. 
1.5.3.1 Transformation 
This process involves transfer of DNA present in solution after cell death/ 
lysis or following release of DNA into the environment. 19 Bacteria that are able to 
take up free DNA are termed `competent'. Some bacterial species are always in a state 
to accept DNA, whereas others become competent at specific time points or as a result 
of changes in environmental conditions, such as in the presence of calcium chloride. 
Transformation has the potential to transfer DNA between distantly related organisms. 
Efficient transformation in certain bacterial species such as Neisseria gonorrhoeae 
and Haemophilus influenzae requires the presence of specific recognition sequences 
which are present in their respective genomes 78'219 Although the presence of specific 
uptake sequences enhances the transformation efficiency between related species, 
many of the naturally competent bacterial species do not display sequence preference 
and are capable of high, levels of transformation. 74 However, transformation 
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proficiency does not necessarily translate into correspondingly high rates of 
interspecies gene transfer. 173 
1.5.3.2 Transduction 
This is the process of DNA transfer through independently replicating viruses, 
called bacteriophage, that infect a range of bacteria. This does not require the donor 
and recipient cells to be present at the same time or place. Phage-encoded proteins 
mediate the delivery of double-stranded DNA into the recipient cytoplasm, and can 
promote the integration of DNA into the chromosome and protect the transferred 
sequences from degradation by host restriction endonucleases. The genomes of phage 
can range in size from a few to several 100 kb, the amount of DNA that can be 
transferred in a single event being limited by the size of the phage capsid. Essential 
bacteriophage genes include specific replicase genes, genes encoding phage 
components and genes encoding the proteins that package DNA in a protein coat. 
Bacteriophages may replicate vigorously and lead to lysis of host bacteria, or 
may become integrated into the genome when they are non-lytic and termed 
prophage. Integrated phage is replicated along with the host chromosome and passed 
on to the daughter cells, but can be triggered by environmental stimuli such as DNA 
damaging agents to enter into the lytic stage. During cell lysis, host cell DNA can be 
packaged and later transferred to a new bacterial strain. New genetic material can be 
introduced into a recipient by donor DNA fragments or the donor genes adjacent to 
the phage attachment site. Although phages are prevalent in the environment, the 
spectrum of microorganisms that can be transduced depends upon the presence of 
specific receptors which are recognized by bacteriophage. As a result, this type of 
gene transfer is limited to related bacterial species. 
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1.5.3.3 Conjugation 
Conjugation is the process of gene transfer via mobile self-replicating 
elements termed plasmids. These encode proteins required for conjugation and 
excision from the donor, and some other factors that may be required for survival in a 
restricted environment. These genetic elements encode proteins that facilitate their 
own transfer from the donor plasmid-carrying cell to a recipient cell that lacks the 
plasmid. Preparation of the DNA prior to transfer is similar among conjugative 
systems but the mechanism of mating-pair formation varies between organisms. 
Actively transmissible conjugative elements range in size from approximately 40 to 
250 kb and are of low copy number. 94 The conjugative or transferable genetic 
elements establish a stable mating pair and trigger DNA transport from the donor to 
the recipient cell through a specialized transfer pore called a conjugation bridge. This 
bridge provides protection to the DNA from the action of environmental nucleases. 
There are several types of conjugative mechanisms, the greater distinctions 
being between those of Gram-positive compared with Gram-negative bacteria. The 
effects of conjugation for Gram-negative bacteria include the acquisition of antibiotic 
resistance. This is a particular problem within hospital settings where antibiotic usage 
is high, such as in an intensive care setting. Since the recipient cell becomes a donor 
after transfer of a plasmid, it is easy to see why an antibiotic resistant gene carried on 
a plasmid can quickly convert a sensitive population of organisms into a resistant one. 
In addition, prophages can undergo recombination with other mobile genetic elements 
that reside outside or within the same bacterium, and this can contribute to a "mosaic 
structure" of genomic islands. 
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Despite the diversity of mechanisms mediating genetic exchange among 
prokaryotes, the introduction of DNA into a recipient cell's cytoplasm does not ensure 
successful gene transfer unless the transferred sequences are stably maintained in the 
recipient microorganism. In addition to the process of acquiring sequences, expression 
of the acquired gene(s) at a significant level is required. The latter step depends on the 
compatibility of the transferred genes with the transcriptional and translational 
machinery of the host organism. 75"73 Stable incorporation of foreign DNA into 
bacterial genomes can be mediated by any of the following processes: 
1. Persistence of the mobile genetic element as an episome, which requires 
selection to avoid loss. 
2. Homologous recombination (usually take places among closely related taxa). 
3. Integration mediated by - bacteriophage integrales or mobile element 
transposases. 
4. Illegitimate incorporation through chance double-strand break repair, as 
postulated for the integration of mitochondrial sequences into the yeast 
genome. 196 
The type and number of genes transferred seems to be limited only by the 
selective pressures of the host or niche, rather than by any characteristic of the core 
replicative genes of the mobile genetic elements. 
1.5.4 Classification of genomic islands 
1.5.4.1 Pathogenicity islands (PAI) 
The term Pathogenicity Island (PAI) was coined by Hacker et al. in 1990. 
Currently, this term is commonly used to describe regions in the genomes of certain 
36 
pathogens that are absent in the non-pathogenic strains of the same or closely related 
species. These regions may contain continuous blocks of virulence genes. PAls have 
recently been characterized in a wide range of bacterial pathogens. This has led to the 
identification of many virulence factors, and has increased our understanding of the 
evolution of bacterial pathogenicity. 
PAIs were first described in Escherichia coli, 95 but have recently been found 
in the genomes of various pathogens for humans, animals and plants. PAls are 
genetically unstable elements, many of which carry genes encoding adhesins, toxins 
or other virulence factors. 126 PAls in enteropathogenic and enterohaemorrhagic strains 
of E. coli, which are important human and veterinary pathogens, are well described. In 
brief, enteropathogenic E. coli (EPEC) is an important cause of diarrhea in infants and 
travelers in underdeveloped countries or regions with poor sanitation. Disease 
manifestations vary from minor gastroenteritis to a severe cholera-like syndrome. 
EPEC are acquired by ingestion of contaminated food and water, and adults in 
endemic areas appear to develop immunity. 165 Enterohaemorrhagic E. coli (EHEC) 
can cause a spectrum of diseases ranging from uncomplicated watery diarrhoea to 
bloody diarrhea and hemorrhagic colitis occasionally with haemolytic-uraemic 
syndrome. EHEC produce a cytotoxin (Shiga-like toxin or Vero toxin), which is 
believed to be important in the pathogenesis of the bloody diarrhea., 71 These 
pathogenic E. coli are closely related to each other and there is some evidence that a 
clone of EHEC is derived from EPEC. Both EPEC and EHEC appear to have evolved 
over time from non-pathogenic strains of E. coli by accumulating a variety of 
virulence factors, such as type III secretion systems (TTS3), the secreted translocator 
proteins and the secreted effector proteins. These functionally different modules have 
been termed the locus of enterocyte effacement (LEE) PAI. Both E. coli strains, 
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EPEC and EHEC, share the same LEE but EHEC contains 13 more ORFs within LEE 
than EPEC. Hypothetically, the remaining ORFs belong to phage-encoded Shiga 
toxins and have probably been acquired at a later time point. On this basis, EHEC 
may have evolved from EPEC via acquisition of a putative prophage element. 
178,195 
1.5.4.2 Metabolic islands 
Acquisition of genes that alter metabolic properties of bacteria allow recipient 
organisms to explore new environments and endows selective advantages under 
specific environmental conditions. Molecular genetic analyses have established that 
species-specific metabolic traits can be attributed either to the acquisition of genes 
through horizontal gene transfer' or to the loss of ancestral genes from a given lineage. 
Mobilization of complex metabolic traits depends on transfer of physically clustered 
genes in a single step. As a result, horizontal inheritance will select for gene clusters 
that act together (operons), which can be expressed in recipient cells by a host 
promoter at the site of insertion. For instance, some bacteria of the Pseudomonas 
group that are part of the plant rhizosphere carry genomic islands that encode 
enzymes involved in degradation of phenolic compounds. ' 90-192 These can help in 
enhancement of the capacity of bacteria to grow and disseminate in the soil. In 
addition, the symbiosis islands of the family Rhizobiaceae carry nitrogen fixation 
genes whose products are necessary for the interactions of these bacteria with plant 
cells. 
The discovery of genomic islands has accelerated with the advent of whole 
genome sequencing. There are currently more than 380 completed bacterial genomes. 
This has led to the observation that many bacteria carry genomic islands and may 
have multiple different islands. 
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Genomic islands can be used as molecular markers for the purposes of 
bacterial identification. These methods can also be applied for estimation of its 
pathogenic potential and even its antibiotic resistance pattern. This can be achieved by 
high sensitivity techniques such as Polymerase Chain Reaction (PCR) and Microarray 
DNA-Chip analysis. 
1.6 B. pseudomallei multilocus sequence typing (MLST) 
1.6.1 General background 
Clinical microbiologists are often asked to determine whether bacterial isolates 
are related to, or distinct from each other. Consequently, numerous typing schemes 
have been developed, including bacteriophage typing, serotyping and biotyping 
(metabolic capabilities of cell). For B. pseudomallei, various strain typing methods 
have been developed. These include ribotyping, 'g', 212,245 PCR-based methods, 256 
random amplified polymorphic DNA (RAPD) analysis, 139' 139,187 variable-number tandem 
repeats (VNTR), '44 and pulsed-field gel electrophoresis (PFGE). 63 Many of these 
methods suffer from lack of reproducibility both within and between laboratories. 
Multilocus sequence typing (MLST), a system based on multilocus enzyme 
electrophoresis (MLEE), overcomes this problem. This has become the preferred 
typing method for epidemiologic and phylogenetic studies for a range of organisms 
because of its portability and unambiguous output data. 49 
1.6.2 Basis of MLST methodology 
MLST is a nucleotide sequence-based approach that compares the sequences 
of housekeeping gene fragments, now aided by comparison with sequence held in 
several databases that can be accessed via the internet. 149 This technique was 
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developed using a similar approach to that used by MLEE, a typing scheme that 
analyses the phenotype of housekeeping enzymes. 
MLEE was first described for the study of mammals in 1971210 It was 
subsequently applied to the study of E. coli in 1973.157 This protein-based method 
determines the mobility of a selected set of metabolic enzymes across a starch gel 
matrix. This involves 20 or more loci, and the alleles at each locus go towards 
defining an electrophoretic type (ET). An assumption is made that differences in the 
mobility of enzymes are the result of molecular mass, electrical charge and 
conformation. Protein migration is directly related to its amino acid sequence. Charge 
differences due to amino acid substitutions in the polypeptide sequence reflect 
changes in the DNA encoding the polypeptide. Not all mutations at the DNA level 
have consequences for the amino acid sequence, and post-translational modifications 
are not usually taken into account in the interpretation of the results. Thus, strains 
showing identical migration patterns for one enzyme will not be distinguished by 
MLEE but may have different genetic alleles at that locus. Thus, MLEE has its 
limitations, and in addition is difficult to perform and produces results that are 
difficult to compare between laboratories. 
MLST was first described in 1998 for the human pathogen Neisseria 
meningitidis. 149 MLST defines alleles at each of 7 housekeeping gene loci on the basis 
of nucleotide sequence of 400 to 600 bp internal fragments. The seven loci are chosen 
so as to be well separated and scattered on the chromosome in order to assess the 
contribution of recombination to the variation within each species 96 There are three 
main factors to consider for the design of a new MLST scheme: (i) the choice of 
isolates to be used in the initial evaluation; (ii) the choice of genetic loci to be 
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characterized; and (iii) the design of primers for gene amplification and nucleotide 
sequence determination. 5' 
Once sequence is obtained for a given locus, this is checked with the 
complementary strand and then compared with all of the previously identified 
sequences at that locus. Allele numbers are then assigned at each of the seven loci, a 
new number (the next available ascending number) being assigned to a new allele 
(defined as any sequence with one or more base pair differences from other known 
sequences at that locus). The combination of the seven allelic numbers defines the 
allelic profile, and each profile (ex. 2-2-1-3-4-2-1) is assigned a sequence type (ST). 
The process by which numbers are assigned to alleles and sequence types means that 
these are uninformative in terms of inter-allele or ST relationships. 148 An overview of 
the process is shown in Figure 1.3. 
MLST has several advantages over MLEE. A greater degree of variation can 
be detected by MLST, since many more alleles are assigned per locus compared with 
MLEE. MLST is based on the nucleotide sequence while MLEE defines a phenotypic 
property. Sequence data can be compared readily between laboratories, such that 
MLST is fully portable, and data stored in a single expanding central multilocus 
sequence database can be interrogated electronically via the internet to produce a 
powerful resource for global epidemiology without exchanging strains. MLST also 
has the advantage that it can be applied directly to clinical specimens, reducing the 
need for bacterial culture. '49 
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Figure 1.3 Overview of MLST (reproduced from225) 
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1.6.3 Use of MLST databases 
At the time of writing, there are 41 species represented in MLST databases 
and published schemes. There are three separate MLST sites, each consisting of 
several databases and related software. The MLST home page at 
http: //www. mist. net/5 includes links to two pages, namely the PubMLST home page 
at http: //pubmist. ore/6 and MLST databases at the MPI für Infektionsbiologie 
http: //web. mpiib-berlin. mpg. de/mist/. 7'96 These MLST databases are hosted at the 
University of Oxford, UK; Imperial College, London, UK; and the Max Planck 
Institute for Infection Biology, Berlin, Germany, respectively. 
MLST users can access information on primer sequences and PCR conditions, 
sequencing protocols, and can use the databases to assign allelic numbers and STs. 
Web databases also provide downloadable submitted data of isolates and allelic 
profiles. Web-based programs for MLST data analysis (some available for free- 
download) are also provided. Sequence from an uncharacterized strain is submitted to 
the appropriate website, and alleles at each locus or multiple loci can be obtained 
either separately or together through the enquiry procedure. Each MLST website holds 
the sequences of all known alleles at each of the seven loci, and all known allelic 
profiles, and through the curator assigns new allele numbers and STs. 
1.6.4 MLST scheme for B. pseudoinallei 
The B. pseudomallei MLST scheme was established in 2003 by Godoy and 
colleagues for epidemiological studies of melioidosis. This characterized B. 
pseudomallei and the closely related organisms, B. mallei and B. thailandensis 90 
MLST data can be accessed via the B. pseudomallei MLST website 
8 (http: //bpseudomallei. mist. net/). Candidate housekeeping genes involved in essential 
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metabolic processes were selected by using BLASTX with sequence contigs of B. 
pseudomallei strain K96243. Complete genome sequencing of K96243 revealed that 
all 7 genes were located on chromosome 1. This study demonstrated that MLST was 
able to discriminate between B. pseudomallei, B. mallei and B. thailandensis. B. 
mallei appeared to represent a single clone that had recently diverged from B. 
pseudomallei. 
1.7 General background to Burkholderia thailandensis 
B. thailandensis is a Gram-negative, motile saprophyte that has been isolated 
from soil in central and northeast Thailand, Laos, Cambodia and Vietnam. 246,262 Early 
reports described the organism as a non-virulent biotype of B. pseudomallei, 32,71,215,245 
but a clear distinction was made in 1998 when the organism was recognized as a 
separate species. 26 16S rRNA gene sequencing, DNA-DNA hybridization and MLST 
profile are consistent with the designation of B. thailandensis as a unique 
species. 6,73,90,275 This bacterium is genetically closely related to B. pseudomallei, with 
which it shares several antigenic and morphologic similarities. 5 217'271 Both species 
grow on the same selective media and have similar biochemical profiles, 216'271'272 but a 
key difference between the two is the ability of B. thailandensis to assimilate L- 
arabinose. B. pseudomallei is unable to do so as a result of a gene deletion event 
involving the arabinose operon, 32 and this distinction is used widely in the laboratory 
as a simple way to distinguish between the two. 15 B. pseudomallei and B. 
thailandensis can also be differentiated by colony morphology when grown on 
modified Ashdown's selective media (Ashdown's selective media plus 100 lg/ml 
streptomycin and 15 lg/ml gentamicin; MASM). 16 B. thailandensis colonies are 
smooth and glossy with a pink pigmentation, while B. pseudomallei colonies are 
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rough and wrinkled with a dark purple pigmentation. 5 It is also possible to 
discriminate between B. pseudomallei and B. thailandensis using species-specific 
PCR222 or Real-Time PCR. 135, vo, 238 
B. thailandensis is generally non pathogenic for animals and humans, and 
disease due to B. thailandensis is extremely rare? " A report from Thailand described 
the isolation of B. thailandensis from purulent material obtained from an amputated 
knee following a motorcycle accident in Thailand, although it is not clear whether this 
was the cause of the infection or a wound coloniser. 140 A case report from the U. S. 
described a boy who was involved in a road traffic accident and near drowning, who 
subsequently developed pneumonia and blood cultures positive for B. thailandensis 88 
Given the frequency of exposure to this organism and the low attack rate, it is clear 
that infection only occurs under exceptional circumstances. This is consistent with its 
low virulence potential in experimental animal models. 69,153,158 In one study, the mean 
50% lethal dose of B. thailandensis in mice was 109 CFU, compared with 182 CFU 
for B. pseudomallei. 215 
Whole genome sequencing of B. thailandensis E264, a strain isolated from a 
rice field in central Thailand, 217 has been performed. This is comprised of two 
chromosomes of 3.8 and 2.9 Mb, respectively, with a total of 5,645 predicted protein- 
encoding ORFs (3282 on Chromosome 1 and 2363 on Chromosome 2, respectively). 
The genome sequence and annotation has been deposited in the GenBank database 
(accession numbers CP000086 and CP000085 for chromosomes I and 11, 
respectively). 128 Comparison of the B. pseudomallei and B. thailandensis genomes has 
revealed broad similarities, including two highly syntenic chromosomes with 
comparable numbers of genes and density of single sequence repeat (SSR) 
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contents. 168 B. thailandensis contains an eight-gene arabinose assimilation operon 
(BTH_II1626-1633) on Chromosome 2 that is absent in B. pseudomallei. 
Conservation of core genes involved in amino acid metabolism, cofactor and carrier 
synthesis, nucleotide and protein biosynthesis between the two species is consistent 
with the ability of B. pseudomallei and B. thailandensis to occupy similar 
environmental niches. 215 
One of the objectives behind whole genome sequencing of B. thailandensis 
was to define the difference in the putative virulence determinant component between 
this and B. pseudomallei. Subtractive hybridization was used as a forerunner to whole 
genome sequencing to identify virulence genes that were present in B. pseudomallei 
but absent in B. thailandensis. 193 Differences have been defined in a range of genes, 
including a capsular polysaccharide gene cluster that was unique to B. pseudomallei. 
Virulence related genes, in particular members of the Type III secretion complex, 
were collectively more divergent between B. pseudomallei and B. thailandensis 
compared to the rest of the genome, possibly contributing towards the ability of B. 
pseudomallei to infect mammalian hosts. 283 71% of B. pseudomallei genes were also 
present as orthologs in B. thailandensis at an average similarity of greater than 80%, 
including TTS2 and TTS3, antibiotic resistance genes, type IV pili-generating 
proteins, hemolysin-related genes, and several adhesion factors and proteases. 
Although a considerable amount of information has been generated to date, the 
precise factor(s) that are absent in B. thailandensis but present in B. pseudomallei that 
confer virulence have not been defined. 
Despite the importance of B. thailandensis in relation to B. pseudomallei, little 
is known about the population genetic structure of the former. An MLST scheme 
developed for B. pseudomallei was found to give sequence at the 7 housekeeping 
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loci. 90 The alleles at all seven loci in the B. thailandensis isolates were different from 
those at the seven loci in all B. pseudomallei isolates, and B. thailandensis formed a 
distinct group. By using the concatenated sequences, the average sequence diversity 
among both the B. pseudomallei and the B. thailandensis STs was 0.2%, whereas the 
average divergence between the STs of the two species was 3.1%. A minimum- 
evolution tree showed that the isolates cultured from the farmer in Oklahoma (see 
above) were distantly related to all isolates of both B. pseudomallei (5.2% divergence) 
and B. thailandensis (4.7% divergence). This study included 10 B. thailandensis 
isolates, and no other studies have been published to date on the population genetic 
structure of this species. 
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1.8 Aims of this dissertation 
The work contained in this dissertation describes a series of studies that 
explore the population genetic structure of B. pseudomallei and the closely related 
organism, B. thailandensis. This was achieved through the use of MLST and an 
evaluation of genomic islands. Specific aims were to: 
1. Determine the presence of putative genomic islands in soil and invasive 
isolates of B. pseudomallei, to compare the frequency between the two groups 
and to examine whether a relationship existed between their presence and 
clinical features/outcome from melioidosis. Genomic islands were also 
considered in relation to the population genetic structure of B. pseudomallei as 
defined by MLST. 
2. Explore the population genetic structure of B. pseudomallei using MLST, to 
compare isolates from the environment with those from invasive disease, and 
to compare isolates from Thailand with those from Australia. Isolates 
associated with a single, well-defined clinical manifestation (parotid infection) 
were examined to determine whether this represented a more restricted 
population. 
3. Undertake typing of an expanded number of B. thailandensis isolates using 
MLST. This was used as a basis for defining the relatedness of B. 
thailandensis and its closely related species, and to define the utility of MLST 
as a typing tool for this species. 
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Chapter 2. Materials and Methods 
2.1 Chemicals and reagents 
All chemicals and reagents were obtained from Sigma-Aldrich Company Ltd. 
or Merck Ltd. Bacterial culture media were obtained from Oxoid. Sterile plasticware 
was obtained from Falcon, Becton Dickinson Ltd. and Terumo. 
2.2 Bacterial culture and storage conditions 
(a) Liquid media: B. pseudomallei and B. thailandensis were grown in Trypticase 
soy broth (TSB) under static conditions at 37°C in air. Cultures were routinely grown 
in 3 ml of media contained in 15 mL universal containers. 
(b) Solid media: All agar plates used in this study were prepared as recommended 
by the manufacturer (Appendix I). B. pseudomallei and B. thailandensis were 
routinely cultured on Ashdown's Selective Agar (ASA) at 37°C in air (Appendix I). 
(c) Bacterial storage: B. pseudomallei and B. thailandensis were suspended in 
TSB containing glycerol (15%, v/v) and stored at -80°C. 
2.3 Laboratory facilities 
All experimental work involving viable bacterial cells was performed in a 
Category 2 containment facility under negative pressure of -50 pascals. All infectious 
work was carried out within a class II biological safety cabinet. 
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2.4 B. pseudomallei identification 
The B. pseudomallei isolate collection used during this work was maintained 
in locked -80°C freezers at the Wellcome Unit, Faculty of Tropical Medicine, 
Mahidol University. All isolates were identified in the clinical diagnostic laboratory in 
Ubon Ratchathani as B. pseudomallei using the following criteria: 
(i) Growth on Ashdown's agar with typical colony morphology after >_48 
hours of incubation at 37°C in air. 
(ii) Oxidase test positive. 
(iii) Resistant to Gentamicin (disc strength 10µg) and Colistin (disc 
strength 10µg) after overnight incubation at 37°C in air on Columbia agar (National 
Committee for Clinical Laboratory Standards, 2000). 
(iv) Bacterial colonies on agar plates were confirmed as B. pseudomallei 
using a latex agglutination reaction. 13,269 In brief, a small amount of colony is 
emulsified using a sterile toothpick into a solution containing latex particles coated 
with a mixture of three monoclonal antibodies specific for a 200-kD surface antigen 
of B. pseudomallei. The reaction is read within 1-2 min. The presence of agglutination 
is taken as a positive reaction. E. coli is used as a negative control. 
(v) API 20NE biochemical strips were used as recommended by the 
manufacturer (bio-Merieux. Inc. ), if any uncertainly remained about the bacterial 
species. Typical API profiles are 1156577,1556577 or 1156576 by APILAB Plus 
software, which gives an automated interpretation on a computer workstation 
(bioMerieux, 2005). 
To exclude the possibility that some isolates were B. thailandensfs, all isolates 
were tested for their inability to assimilate arabinose. This was performed in batches 
at the end of the rainy season of each year in the Wellcome Unit, Bangkok. B. 
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pseudomallei is negative and B. thailandensis is positive. 269 Isolates were point 
inoculated onto agar plates containing arabinose as the only source of nutrition 
(Appendix I). B. pseudomallei fails to grow on this medium after 48 hours incubation 
at 37°C in air, while B. thailandensis shows growth. 
2.5 Bacterial isolates 
2.5.1 Isolates used for genomic island analysis 
A total of 186 B. pseudomallei isolates were obtained from northeast Thailand. 
Of these, 83 were isolated from the environment in the province of Ubon Ratchathani, 
northeast Thailand between 1990 and 2003. 
2.5.2 Isolates used for MLST 
A total of 266 B. pseudomallei isolates were characterized by MLST. Of these, 
83 were the environmental and 103 the clinical isolates described above. A further 79 
isolates were associated with a single clinical syndrome (acute suppurative parotitis in 
children). These were cultured from consecutive patients presenting to 
Sappasithiprasong hospital with parotitis since 1986. A total of 77 B. thailandensis 
isolates were obtained from soil collected from central and northeast Thailand. 
2.6 Extraction of genomic DNA 
Bacterial isolates were streaked from the freezer vial onto Ashdown's agar. A 
single colony was inoculated into TSB and incubated overnight in air at 37°C, after 
which genomic DNA was extracted using the Wizard Genomic DNA purification kit 
(Promega). DNA concentration was determined using the spectrophotometric 
method. 202 Stock DNA was maintained at -80 T. 
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2.7 Polymerase chain reaction (PCR) to detect genomic islands 
2.7.1 Introduction 
The presence or absence of 5 genomic islands was defined by PCR (see Table 
2.1). These were selected from the 16 possible islands so as to represent the range of 
island types described for the sequenced B. pseudomallei strain K96243 (prophage, 
prophage-like, putative integrated plasmid and metabolic island). 104 The target genes 
were predominantly putative hypothetical proteins of unknown function; genes that 
encoded functions necessary for the transfer and maintenance of the island, such as 
integrases, were avoided as similar sequences may be found on other unrelated 
islands. 
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2.7.2 PCR to detect the 
. presence 
of genomic islands 
Two target genes were selected for each genomic island, as follows: 
BPSLO130 and BPSLO135 (island 2), BPSL1138 and BPSL1155 (island 6), 
BPSL2578 and BPSL2579 (island 9), BPSL3258 and BPSL3260 (island 11), and 
BPSS2053 and BPSS2061 (island 16). Primer design was based on the whole genome 
sequence of B. pseudomallei K96243 using PrimerSelect (Lasergene V6.1, DNAstar, 
USA). The primer pairs used to amplify genes situated within genomic islands are 
shown in Table 2.2. The specificity of primer sequences for the chosen gene was 
confirmed through BLASTN analysis using the K96243 whole genome sequence 
((http: //www. ncbi. nim. nih. gov/BLAST/), 9 accession number NC 006350 and 
NC_006351, for Chromosome I and chromosome II, respectively. ). 
PCR amplifications were performed using a PTC-0200 DNA engine (MJ 
Research, Cambridge, USA). Primers were multiplexed in three reactions (Table 2.2). 
Each 10 µl of PCR mixture contained 1X reaction buffer, 1.5 mM MgCl2,0.7 µM of 
each primer, 1 gi of working template DNA, 200 pM of deoxynucleotide triphosphate 
(dNTP) and 0.5 U of Tag DNA polymerase (Promega, USA). Reaction mixtures were 
pre-heated to 95°C for 2 minutes followed by 35 cycles of 95°C for 30 seconds, 
specific annealing temperature for 30 seconds and 72°C for 1 minute. A final 
extension at 72°C for 5 minutes was followed by cooling to 4°C. A positive control 
(B. pseudomallei K96243) and a negative control (reaction mixture without DNA) 
were included in each PCR run. Aliquots of reaction mixtures were analyzed by 2% 
agarose gel electrophoresis. Bands were detected by staining with ethidium bromide 
and visualization under UV light using the Gel Doc 2000 System (Bio-Rad, USA). A 
single product of the predicted size was interpreted as a positive result for a given 
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gene. The presence of one or both genes in a given island was interpreted to mean that 
the given island was present. 
2.7.3 PCR to confirm absence of genomic islands 
For isolates negative for a given island, a process of further verification was 
undertaken in which a PCR reaction was performed to amplify across the putative 
insertion site. Primers were designed in flanking genes, and the extension time set to 
amplify the region across the site in the absence of an island. If an island was present, 
this reaction would fail to give a product. This strategy is summarized in Figure 2.1. 
Primer pairs were designed using PrimerSelect (Lasergene V6.1, DNAstar, 
USA). Specificity of each primer pair was verified as before. Primers and cycling 
conditions are shown in Table 2.3. Amplification across genomic island 9 had an 
extension time of 1 minute 30 seconds, while 1 minute was used for other genomic 
islands. 
Two positive products for each insertion site were randomly selected and 
verified by sequencing. Products were purified and sequenced as described in 2.9.3 
and 2.9.4. Sequences were compared with the genome sequence of K96243 using 
SeqMan II (Lasergene V6.1, DNAstar, USA) and BLASTN search 
(http: //www. ncbi. nim. nih. fzov/BLASTý/). 9 
55 
a U 
a 
E 
wo 
Z 
GA 
iw 
.. r it 
Qr 
1ýr 
bD 
10 
ei 
it 
it 
a 
N 
H 
Ci 0 M 
O N N . ) O In nt 0 0 c' C) 
N M 
0 (ý .. Co l[) . - - -t N -t N 
CL 
cm c V V V 
0) 
0) ri ci LO 
ca 
ih 
v 
ä) 
E 
o. 
a) 
Lo 
a) 
a) 
f- C? 
v 
0) 
E 
a 
v 
Co 
0 U- 
0 
4) 
C a, 0 
I- 
I -U C7 Q 
0<0 
0- 
oh- Ü I- Q cUU 
U 
U 
Ua 0Q 
00 0U 
000 
000 
00ä 
000 
ÜU0 
0 
U 
C7 
H 
UU 
F- U 
Ü0 
U I- U 
1- 
Ü 
I- 
C7 C7 Cý U U 
00 CV) 00 NÖ 
NU) J 
(N/) 
Cl) Cl) ä 
Mmm 
Ü Ü 0 
V 
C9 
U V 
Ü 
a ý Ü 
U' U' 
0 U U V 
C9 
C7 
0 a (D (D F - 
Ia- 
UÜU 
QÜ 
QU0 
Ü0Ü 
E- U 
UUÜ 
QU0 
C: ) LO m 0 
N 
f7 
Cl) ä Cl) m 
M m m m 
x aD 
Z 
UU 
F- U U 
UaÜ 
Ü 
UU' 
VÜ 
ÜU 
U H 
VQ 1ý- 
U 
C7 
c I"- U 
0< 
01- 
00 
ÜÜ0 
Ü ~U' Ü 
U1-00 
000 
01-0 
Q9Ü C 
000 
01-0 
Q 0 
~Q 
Uý 
Li) OD r- M cv) (p 
4JN 
CO U) CL CL rL 
M Co m 
"o l) 
Genomic island present No island present 
FýF 
RR 
PCR 
(with time limitation) 
PCR product 
ý........ ........ ý -310 ........ *- 
No band detected 
Figure 2.1 PCR strategy to confirm lack on genomic island 
9 
band detected 
57 
U 
O (L) a ä y 'n 
c 
H 
6J 
af°i ä ö c 
6A 
H 
M 
vý N E 
u a 
bD N 
Q 13-1 
a E 
b 
D c'ý 
A uý 
d a 
v 
i. N 
u 3 
*Z: LL 
a 
M V 
ri E c c? c 
, 
ce CD N E-4 
N- N 
Öl 
CD ca 
a-- 1- . -- Q) e- 
0 U) In U) p 
M r- M 
V U Ü Ü (j 
o 0 
Co Le) LO M to to to 
U 
ý F - Q U U U Q U F- 
U 
U` ~ (D 
U C9 F- Ü ý7 
U Ü Ü 
C 7 F- U U 
Ü 
CCD U V Ü 
U F- 
U U Cý 
, 
CD 
Ü 
U 
~ U Q 
H Q 
Q 
Ü 
U Ü U f" ý 
U Ü U 
C7 
Ü 
I - 
F- 
`ý 
Ü Ü U (D U Cý U (7 U Q U U C7 
(D F- c) ci (D 
U U U 0 CD 
C14 
00 W) 
2.7.4 Analysis of genomic island data 
An island was classified as present if either or both target genes were positive, 
and negative if no amplification products were obtained for either target gene, 
together with a PCR product across the putative insertion site. Comparison of genome 
sequences for GIs was performed using the ACT (Artemis Comparison Tool) suite of 
programs (www. sanger. ac. uk Software ACT). 30 Statistical tests were performed 
using the statistical program STATA/SE, version 9.0 (StataCorp LP, College Station, 
Tx. ). Proportions were compared using the Chi-square test or Fisher's exact test, as 
appropriate. Comparison of continuous data was performed using the Student's t test. 
Unifactorial analysis was used to examine the association between presence of each 
GI, cumulative number of GIs, and clinical factors. 
2.8 MLST of B. pseudomallei 
2.8.1 Primers 
The primer pairs used to amplify housekeeping gene fragments on 
chromosome 1 are shown in Table 2.4. 
2.8.2 PCR 
PCR was performed using a PTC-0200 DNA engine (MJ Research, 
Cambridge, USA). Reactions were carried out in a total volume of 50 µl. Each 
reaction contained 1X reaction buffer, 1.5 mM MgC12,0.7 µM of each primer, 5 µ1 of 
working template DNA, 200 pM of deoxynucleotide triphosphate (dNTP) and 2.5 U 
of Taq DNA polymerase (Promega, USA). Cycling conditions were an initial 
denaturation at 95°C for 4 min followed by 34 cycles of denaturation at 95°C for 30 
sec, the annealing temperature shown in Table 2.4 for 30 sec, and extension at 72°C 
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for 60 sec. The samples were then maintained at 72°C for 10 min and cooled to 4°C. 
The amplification product was visualized using 2% agarose gel electrophoresis which 
was stained with ethidium bromide and visualized using a Gel Doc 2000 system (Bio- 
Rad, USA). 
2.8.3 Clean-up of PCR products 
The amplified DNA fragments (25 µl) were precipitated by mixing with 60 t1 
of 20% polyethylene glycol 8000/2.5M NaCl for 1h at room temperature or 4°C 
overnight. Following centrifugation at 13,000 rpm for 40 min, the supernatant was 
discarded and the pellet was washed with 600 µl of 70% ethanol. The tube was 
centrifuged again as before. The supernatant was then removed and the DNA pellet 
dried at 37°C for 1h and resuspended with 10 µl of sterile distilled water. 
2.8.4 Sequencing 
The DNA fragments for each strand were sequenced using a DYEnamic ET 
Dye Terminator Kit (Amersham) and a MegaBACE 500 sequencer with nested primer 
pairs shown in Table 2.5. 
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Table 2.4: Primer pairs and PCR cycling conditions used for MLST of B. 
pseudomallei 
Primer name Primer Sequence (5'-3') 
Annealing 
Temp. (°C) s 
Product 
ize (bp) 
Outer aceFwd GCCGCTCGGCGCTTCTCAAA 60 767 
Outer aceRev AGCCGCCGTTCAGCGAAAAATC 
Outer lepAFwd GCATCACGACGCCGACGTAGTTGT 60 724 
Outer lepARev CTGGCGGGCCTTTTCGGCTAAA 
Outer lipAFwd ACGATCCGACCGCCAAGCAGAAGG 60 807 
Outer lipARev ACGTACTCGCGCACCGGCAGATGG 
Outer narKFwd GCCGTCAGCGTGAGCCTCGTCT 60 767 
Outer narKRev AGCCCGCGTTCTGCAACCACA 
Outer ndhFwd TATCCCGCCGATCAGAAACAGTCC 60 719 
Outer ndhRev GCCCGGCTCGCCCTCGTC 
OuterJgltBFwd TGTCGCGGCCCGTCTTCATCT 63 727 
Outer gltBRev ATCAGCACCGAGGCGCATACGAC 
Outer gmhDFwd TCGCGCAGGGCACGCAGTT 65 705 
Outer. gmhDRev GGCTGCCGACCGTGAGACC 
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Table 2.5 Primer pairs used for sequencing of amplification products 
Primer name Primer Sequence (5'-3') 
Nested_aceF GCTCGGCGCTTCTCAAAA 
Nested_aceR ATGTCCGTGCCGATGTAGC 
Nested lepAF TTTCGCTTGATCGGCACTG 
Nested lepAR CGAACCACGAATCGATGATGA 
Nested_lipAF CATACGGTGTGCGAGGAAGC 
Nested lipAR GCAGGATCTCGTCGGTCGTCT 
Nested_narKF GCCACCCGCTCCGCGTGAGC 
Nested_narKR AGCCCGCGTTCTGCAACCACA 
Nested ndhF GCAGTTCGTCGCGGACTATCTC 
Nested_ndhR GGCGCGGCATGAAGCTC 
Nested 
_gltBF 
GGCGGCAAGTCGAACACGG 
Nested_gltBR GCAGGCGGTTCAGCACGAG 
Nested gmhDF TCGCGCAGGGCACGCAGTT 
Nested_gmhDR GTCAGGAACGGCGCGTCGTAG 
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2.8.5 MLST analysis 
The alleles at each of the loci were assigned using the B. pseudomallei MLST 
website (http: //bpseudomallei. mist. net). 8 Novel sequences were repeated, and 
assigned new alleles and deposited in the MLST allele database. Each allele was 
given an allelic number, and the allelic profile used to define sequence type (ST). The 
previously published MLST profiles for 158 strains isolated by Professor Bart Currie 
in Northern Australia were downloaded from the MLST web site for comparison 
(http: //www. mist. net). 5 
Neighbor joining trees were constructed using the Kimura-2-parameter 
method of distance estimation as implemented in MEGA version 2.1. UPGMA 
dendrograms were constructed using the START package available from 
http: //www. pubmist. org. 121 Maximum likelihood congruence analysis of gene trees 
was carried out using PAUP* ver. 4b following the method of Feil et al., 200180 except 
that all trees were reconstructed and scored on the basis of the HKY85+G+r model of 
DNA substitution. eBURST v3 (http: //eburst. mist. net) was used to demonstrate 
relationships between closely related STs (those differing at only a single locus) 8' 
Estimates of synonymous and non-synonymous changes (dS/dN) were calculated 
using the method of Nei and Gojobori as implemented in MEGA version 2.1. Mean 
heterozygosity per locus (H) was calculated using LIAN version 3.1 
ttp"//adenine. biz. fh-weihenstephan. de/liar/) 99 Comparisons of allelic and nucleotide 
divergence were calculated using the program BLAND. Comparisons between 
isolates from Thailand and Australia, and between Thai isolates recovered from soil 
and cases of invasive disease, were carried out using the classification index (Cl) 
proposed by Jolley et al., 2005.122 This parameter is similar to FsT, but is more 
sensitive in cases where more than two alleles are present, as it directly considers the 
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frequencies of each allele. Significant differences in the frequency of STs, and the 
frequency of alleles at specific loci, were identified by comparing the observed 
classification index with those obtained from 10,000 randomized trials. 
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Chapter 3. Results I: Burkholderia pseudomallei genome plasticity: 
genomic island variation in relation to virulence and origins 
3.1 Chapter content 
The time from onset of symptoms of melioidosis to hospital presentation 
varies from hours to months. Disease manifestations are- extremely wide ranging and 
vary from acute, fulminant sepsis to localized disease. The basis for marked 
variability in clinical presentation and disease severity is unknown. The role of 
bacterial factors in determining disease variability and severity is undefined. 
The whole genome sequence of B. pseudomallei K96243 has been 
published. 104 The 7.25Mb genome is divided into two chromosomes, the smaller of 
which (chromosome 2) may have evolved from a megaplasmid. Considering both 
chromosomes, sixteen genomic islands (GIs) have been identified, which encompass 
distinct types of mobile genetic elements. The presence of eleven GIs was found to be 
variable in 40 natural isolates of B. pseudomallei. 104 This is consistent with a key role 
for lateral gene transfer in the microevolution of this species. It was proposed that 
there is considerable variability in the presence of genomic islands within the wider B. 
pseudomallei population, leading to diversity in gene complement within this species. 
Genomic islands in other bacterial species encode many different functions, and 
selection may favor the maintenance of . islands that increase fitness in a specialized 
environmental niche. Genomic islands may also play a pivotal role in virulence of a 
large number of bacterial pathogens, carrying clusters of virulence genes encoding a 
wide range of functions, including iron uptake systems, adhesins, superantigens, and 
genes that alter the antibiotic resistance phenotype. 208 
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The aim of this study was to examine the utility of a range of approaches in 
defining the presence and significance of genomic variation in natural populations of 
B. pseudomallet. This was applied to a representative sample of five GIs previously 
described for B. pseudomallei K96243, the choice being based on inclusion of the 
range of different island types. Comparisons were drawn between isolates obtained 
from the environment and from patients with melioidosis in order to examine the role 
of genomic islands on virulence. An in silico analysis of eight complete genome 
sequences revealed the micro-evolutionary processes responsible for the short-term 
diversification of these regions. The rapid loss and/or acquisition of gene islands were 
observed by assaying the presence of islands within isolates belonging to single 
clones (as defined by MLST data). 
3.2 Bacterial isolates 
A total of 186 B. pseudomallei isolates were obtained from northeast Thailand. 
Of these, 83 were isolated from the environment in the province of Ubon Ratchathani, 
northeast Thailand between 1990 and 2003. All sites were flooded rice paddies, the 
majority of which were sampled after ploughing but before planting. These isolates 
were processed for the presence of B. pseudomallei as previously described by Smith 
et al., 1995.217 Briefly, soil samples were collected from approximately 30 cm depth. 
100 g of soil was added to 100 ml of sterile distilled water then mixed and left 
overnight. The surface liquid of each sample (neat and serial dilutions) was spread 
plated onto ASA and inoculated into selective or enrichment broth. B. pseudomallei 
isolates were identified as described previously in chapter 2. Individual freezer vials 
represented several colonies from each positive site. A further 103 isolates were 
cultured from consecutive patients presenting with melioidosis during 2001 to 
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Sappasithiprasong hospital, Ubon Ratchathani. A single isolate was used from each 
patient. Clinical manifestations of infection were varied; 63 patients had positive 
blood cultures with or without involvement of one or more organs or tissues, and 40 
patients had negative blood cultures but one or more organs or tissues involved. All 
isolates were maintained at -700C in TSB with 15% glycerol. 
3.3 Genomic island identification 
The genomic islands were previously identified during whole genome 
sequence analysis of B. pseudomallei K96243 (accession number BX571965 and 
BX571966). '°4 Five out of sixteen genomic islands were selected as being 
representative of these. These are GI 2, GI 6, GI 9, GI 11 and GI16, which correspond 
to putative prophage, prophage-like, prophage-like, putative integrated plasmid and 
putative metabolic islands, respectively. 
3.4 Clinical definitions 
Multiple organ involvement was defined when there was >1 non-contiguous 
focus of infection, not including blood. Pneumonia was defined as the presence of 
clinical features plus radiographic changes and/or sputum culture positive for B. 
pseudomallei. Impaired renal function was defined as an estimated glomerular 
filtration rate below 60 mL/min/1.73 m2 during admission. Glomerular filtration rate 
was estimated using an abbreviated form of the Modification of Diet in Renal Disease 
study equation. ' Impaired hepatic function was defined as an elevation of 
aminotransferase more than 5 times the upper normal limit or the presence of jaundice 
during admission. Hypotension was defined as a systolic BP <90mmHg on or during 
admission. 
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3.5 Analysis 
Comparison of genome sequences was performed with ACT (Artemis 
Comparison Tool (www. sanger. ac. uk Software ACT)30 using BLASTN and 
TBLASTX . Comparisons were made using 3 additional complete B. pseudomallei 
genome sequences 1106a (accession numbers CP000572 and CP000573), 1710b 
(accession numbers CP000124 and CP000125) and 668 (accession numbers 
CP000570 and CP000571), 6 further B. pseudomallei strains currently undergoing 
whole genome sequencing (406e, 1106b, 1710a, Pasteur 6068, S 13, and 1655) by The 
Institute of Genome Research (TIGR; http: //www. tigr. org), and B. thailandensis E264 
(accession numbers CP000086 and CP000085)283 
Statistical tests were performed using the statistical program STATA/SE, 
version 9.0 (StataCorp LP, College Station, Tx. ). Proportions were compared using 
the Chi-square test or Fisher's exact test, as appropriate. Comparison of continuous 
data was performed using the Student's t test. Unifactorial analysis was used to 
examine the association between presence of each GI, cumulative number of GIs, and 
clinical factors. 
3.6 Results and discussion 
3.6.1 Overview of five genomic islands in B. pseudomallei strain K96243 
The five genomic islands studied here include examples of prophage (GI 2; 
K96243) which have been shown to be mobile in this strain, 104 two prophage-like 
islands (GI 6 and GI 9), a putative integrated plasmid (GI 11), and a putative 
metabolic island (GI 16) that lacks any obvious genes for mobilisation or integration. 
The criteria used to identify these island regions were wide; as with many genomes, 
no single characteristic typical of genomic islands is shared by all of these regions. 
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For example, some of the islands contain integrase genes, some are located next to a 
tRNA gene and are flanked by direct repeats, and others have anomalous base 
composition. Atypical base composition is indicative of fairly recent acquisition of the 
island through horizontal gene transfer by B. pseudomallei, while islands with typical 
base composition for the genome are likely to be more ancient and stable integrations 
into the genome. By assaying the presence of these islands in a large strain collection 
within the population framework provided by the MLST data, it is possible to 
investigate the frequency of island acquisition and loss, as well as their possible role 
in disease. 
A summary of the gene content of each of the five GIs in B. pseudomallei 
K96243 is provided in Table 3.1, and a comprehensive list is provided in Appendix 
III. The overwhelming majority of genes that are not phage or plasmid related are of 
unknown function. Four GIs (2,6,9 and 11) do not contain genes with homology to 
those with known metabolic or putative virulence functions. However, GIs 2,6 and 11 
contain low %GC regions relative to the rest of the island, indicating that the islands 
are mosaic and some genes may have been acquired very recently. GI 16 contains 
several CDSs with similarity to known virulence determinants, including a putative 
haemagglutinin and processing protein, and genes involved in the acquisition and 
utilization of nutrients. The abundance of CDSs on this island that encode functions 
that potentially broaden the metabolic repertoire of K96243 (for example, possible 
sugar utilization and amino acid catabolism gene clusters and accompanying 
regulators), has led to this island being previously designated a putative metabolic 
island. 104 CDSs in this island region exhibited varying levels of similarity to proteins 
from a range of taxonomically diverse organisms, and it was not possible to speculate 
on the likely source of this island region from similarity searches. 
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3.6.2 Sampling framework for B. pseudomallei isolates 
Google Earth software was used to map the geographical site of isolation for 
environmental isolates (Figure 3.1), and the home address of patients with melioidosis 
grouped according to Amphoe (second level administrative districts) (Figure 3.2). 
There was considerable overlap in location of environmental isolates and patient 
address, and on this basis it is suggested that soil and invasive isolates do not 
correspond to distinct sub-populations. 
70 
Table 3.1 Overview of gene content within five genomic islands of 
B. pseudomallei K96243 
Island Gene classification No. CDSs Functional Notes 
GI 2 unknown function 27 3' region of the prophage contains a predicted 
bacteriophage structural and 22 membrane protein with no database matches in 
regulatory proteins a low %GC region: BPSLO176 (55.9% GC) 
GI 6 unknown function 16 5' region of the island contains two CDSs in a 
bacteriophage-related proteins 5 low %GC region: BPSL1137 (45.7% GC) and 
additional functional proteins I BPSL1138 (46.5% GC) that encode a putative 
nucleotide binding protein and conserved 
hypothetical protein with a ReIA / SpoT 
conserved domain. 
GI 9 unknown function 17 Bacteriophage like-proteins include an 
bacteriophage-related proteins 2 integrase and a phage-like regulatory protein 
GI 11 unknown function 7 Plasmid like-proteins include conjugal transfer 
plasmid-related proteins 7 proteins and plasmid replication protein 
GI 16 unknown function 1I This islands encodes several metabolic and 
transport proteins 8 transport functions that may be important in 
metabolic proteins 6 the generation and acquisition of nutrients. 
regulatory proteins 2 Theis includes two ATP Binding Cassette 
transposase proteins 3 transporter type systems, and a L-asparaginase, 
misc. functional proteins 8 fatty aldehyde dehydrogenase, and putative 
pseudogenes and gene 4 alpha-galactosidase. The island also includes a 
remnants putative cell surface haemaglutinin protein and 
two-partner secretion system protein that may 
have a role in niche colonization or virulence. 
71 
ý 7- '_ 
,I 
4 10 , 
fl, 
wý 4 
Figure 3.1 Geographic origin of 83 B. pseudomallei isolates cultured from the 
environment in Ubon Ratchathani, northeast Thailand. Red dots demonstrate sites 
of isolation of environmental isolates. 
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Figure 3.2 Geographic origin of 103 B. pseudomallei isolates cultured from 
patients with melioidosis in Ubon Ratchathani, northeast Thailand. Green dots 
show the areas of residence of patients with invasive melioidosis, grouped into 
Amphoe (second level administrative districts). The size of the dot is proportional to 
number of cases, with larger dots representing a larger number of cases. 
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3.6.3 Presence of five genomic islands in B. pseudomallei 
Presence or absence of the five GIs was defined for 186 Thai isolates obtained 
from the environment (n=83) and from patients with melioidosis (n=103). The 
proportion of all isolates positive by PCR varied between GIs, and ranged from 12% 
for a prophage-like island (GI 9) to 76% for a metabolic island (GI 16) (Table 3.2). 
These proportions are consistent with previous findings reported for 40 Thai 
isolates, 104 with the exception that GI 2 and GI 6 were more frequently detected in the 
larger bacterial population examined here (72% versus 53% for GI 2, and 23% versus 
8% for GI 6, p=0.02 & p=0.03, respectively). Isolates in both collections were from 
northeast Thailand. A very small proportion of strains were positive for one or two 
gene targets for a given GI, and gave an amplification product for PCR across the 
putative insertion site. One explanation for this is that GIs may have alternative 
insertion sites. This explanation is shown to be true for some islands in the sequenced 
strains (see analysis of the sequenced strain GIs below). 
3.6.4 Comparison of the presence of genomic islands in soil and invasive isolates 
The hypothesis that GIs play a role in the ability to cause human disease was 
examined by testing whether their presence was significantly different in clinical 
vesus environmental isolates. There was no significant difference in the presence of 
any of the GIs between these two groups (p>0.05 for all five islands) (Table 3.2). The 
possibility remained that combinations of GIs could alter the ability to cause disease 
through either a cumulative or synergistic effect. The cumulative number of GIs per 
isolate was defined for the 186 Thai isolates; this ranged from 0 to 5 (median 2, IQR 1 
to 3) (Table 3.3). The distribution of cumulative GI number did not differ between 
environmental and disease-associated isolates (p=0.27) (Table 3.3). These data 
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indicate that none of the islands examined were numerically associated either 
individually or on a cumulative basis with the ability to cause melioidosis. 
Table 3.2 Presence of five genomic islands in 186 B. pseudomallei isolates 
Genomic Positive (%) Positive (%) P° 
island All isolates 
(n=186) 
Soil 
(n=83) 
Invasive 
(n=103) 
2 133 (72%) 62 (75%) 71(69%) 0.39 
6 43 (23%) 22 (27%) 21(20%) 0.33 
9 22(12%) 11 (13%) 11 (11%) 0.59 
11 39(20%) 15 (18%) 24(23%) 0.38 
16 142 (76%) 66 (80%) 76 (74%) 0.36 
° Chi-square 
Table 3.3 Cumulative presence of genomic islands in 186 B. pseudomallei isolates 
Cumulative number 
of genomic islands 
All isolates Soil Invasive pa 
0 5 (3%) 1 (1%) 4 (4%) 0.27 
1 46 (25%) 20 (24%) 26 (25%) 
2 84 (45%) 36 (43%) 48 (47%) 
3 40 (22%) 20 (24%) 20 (19%) 
4 10 (5%) 6 (7%) 4 (4%) 
5 1(0.5%) 0 1 (1.0%) 
Student's T test 
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3.6.5 Relationship between clinical features and genomic islands in disease- 
associated isolates 
The lack of association between the presence of the five GIs and the ability to 
cause human disease does not exclude the possibility that these GIs are associated 
with specific clinical features or outcome. To study this, a detailed statistical analysis 
was undertaken of the relationship between a range of clinical features in 103 patients 
with melioidosis and the presence of GIs in their associated B. pseudomallei isolates. 
Univariate analysis was used to compare the presence of each GI and their cumulative 
number with the presence of blood cultures positive for B. pseudomallei, disease 
distribution, presence of ultrasound confirmed abscess(es) in liver and/or spleen, lung 
involvement as defined by abnormal chest radiograph consistent with infection, the 
presence on admission or subsequent development of hypotension, impaired renal 
function and/or impaired liver function, and death during hospital admission. GI 6 
was negatively associated with positive blood culture, and GI 11 was negatively 
associated with impaired renal function (Table 3.4). Cumulative number of GIs was 
negatively associated with impaired renal function. 
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These significant associations could be a chance finding related to multiple 
comparisons. To test this hypothesis, the presence of GIs were determined for an 
independent set of 255 invasive isolates obtained from patients with melioidosis 
presenting to Sappasithiprasong Hospital between 2002-2003. There was no 
significant association between GI 6 and positive blood cultures (OR 1.12; 95%CI 
0.51-2.43, p= 0.78), or GI II and impaired renal function (OR 0.67; 95%CI 0.34-1.32, 
p=0.25). Cumulative number of GIs was not negatively associated with impaired renal 
function. It can be concluded that there were no significant associations between 
clinical features and any of the five GIs examined. 
3.6.6 Variability in genomic islands between clones of B. pseudomallei 
The mobility of the five GIs was explored by examining whether the presence 
of gene islands reflects the underlying population structure, such that closely related 
isolates might have more similar GI repertoires than distantly related isolates. This 
was possible as all of the isolates had been characterized by MLST, and these data 
revealed the presence of three clonal lineages consisting of very closely related 
isolates: ST 70 (n=15 isolates), ST 54 (n=11), and ST 167 (n=9). The variation in GI 
repertoire was compared within and between these clones. There was considerable 
variability in presence of the five GIs between the three clones (Table 3.5). For 
example, GI 6 was more common in isolates belonging to ST 70 than the other two 
clones (p=0.04), GI 16 was ubiquitous in ST 54 isolates but present in three quarters 
or less in the other two ST (p=0.04), and GI 11 was only detected in 4 isolates 
belonging to ST 70. 
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Table 3.5 Presence of genomic islands in the three largest bacterial clones as 
defined by MLST 
Genomic All isolates Sequence type 
island ST 70 ST 54 ST 167 P 
Number of 
isolates 
186 15 11 9 - 
GI 2 133 (72%) 11(73%) 6 (55%) 6 (67%) 0.60 
GI 6 43 (23%) 8 (53%) 1 (9%) 1 (11%) 0.04 
GI 9 22 (12%) 0 1 (9%) 0 0.57 
GI 11 39 (21%) 4 (27%) 0 0 0.08 
GI 16 143 (77%) 10 (67%) 11(100%) 5 (56%) 0.04 
° Fisher's exact test 
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This suggests that horizontal gene transfer can alter the gene repertoire 
("accessory genome") of this species very rapidly, i. e. before any observable changes 
in the vertically inherited "core" genome, and is consistent with the hypothesis that 
isolates that are identical by MLST might exploit different ecological niches 249 The 
MLST data for B. pseudomallei has revealed a very high frequency of homologous 
recombination resulting in limited clustering and low levels of linkage 
disequilibrium 40,90,97 These results also suggest that the loss and acquisition of 
genomic islands by horizontal gene transfer significantly contributes to the dynamism 
of the genome. However, it should be noted that these two processes are distinct, and 
that a high rate of island transfer does not necessarily predict a high rate of 
homologous recombination or vice versa. For example, MLST data for the Gram 
positive pathogen Staphylococcus aureus has revealed only modest rates of 
homologous recombination, yet the "accessory" genome of this species is known to 
change very rapidly. 79,103,143,177,249 B. pseudomallei represents an alternative scenario, 
the data indicating both high rates of homologous recombination together with rapid 
changes in island repertoire. 
3.6.7 in silico analysis of genomic islands 
An in silico analysis of the five GIs was undertaken to explore the degree of 
variability in presence, structure and chromosomal insertion site. Nine isolates that are 
currently undergoing whole genome sequencing by TIGR were examined and 
compared with strain K96243, which has been sequenced by the Wellcome Trust 
Sanger Institute'04 (Table 3.6). Seven TIGR isolates and K96243 are unique strains, 
but strains 1106b and 1710b were recovered from patients with relapsing melioidosis, 
and are identical by MLST to strains 1106a and 1710a respectively. 
The in silico structure, composition and insertion site of the five GIs was 
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examined using the ten available genome sequences (complete and assemblies from 
unfinished genomes). GIs 2,6,9 and 11 all had flanking repeats, integrases, and 
mobile element-like genes in the other strains, consistent with the suggestion that 
these were recently acquired mobile genetic elements. There were two instances 
where the GI was absent at the predicted site of insertion, but DNA with extended 
similarity to the island was detected elsewhere in the genome (one example each for 
GI 2 and GI 6). This may be due to genomic rearrangement in the same strain over 
time, or may reflect the presence of multiple potential insertion sites for these GIs in 
the B. pseudomallei genome. 
Comparison of GI 1I identified an alternative island inserted at orthologous 
sites in the 1106a and 1106b genomes (Table 3.6, Figure 3.3). This novel island is 
larger than the K96243 GI 11 (-35 kb). Comparison of the islands in 1106a and 
1106b demonstrated that they are virtually identical except for a small internal indel 
region that is present in 1106a but absent in 1106b. The indel region is between two 
identical IS elements in 1106a. In 1106b there is a single IS element, suggesting that 
recombination between the IS elements may have lead to the deletion in this region in 
1106b. Although the 1106a and 1106b islands appear to be inserted at the same site as 
the K96243 GI 11, the attachment sites are different. In the case of K96243, the 
attachment site is an Ala tRNA, generating 45mer perfect repeats that flank the island. 
The GI 11 regions in 1106a and 1106b are next to the Ala tRNA, but the flanking 
DNA in both islands is a 13mer sequence that does not appear to be part of the Ala 
tRNA, or surrounding sequence in K96243. The alternative GI 11 in 1106a and 1106b 
contains a putative filamentous haemagglutinin and processing protein that are similar 
to proteins found in B. thailandensis (BTH_I2723 and BTH I2721 respectively). 
The homologues of the filamentous haemagglutinin and processing protein in B. 
thailandensis strain E264 are not in an orthologous position relative to the B. 
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pseudomallei GI II flanking DNA. In the genome of this closely related species, an 
alternative GI II is present (BTH I3130 to BTH_13143), which is integrated at the 
orthologous attachment site (Ala tRNA) to the GI 11 in B. pseudomallei K96243. 
Table 3.6 Distribution of islands in sequenced B. pseudomallei strains 
BP strain Origin GI 2 GI 6 GI 9 GI 11 GI 16 
K96243 Thailand + + + + + 
406e Thailand - - - - NC 
1106a Thailand - - -* Alt +/- (BPSS2057 to BPSS2076) 
1106b Thailand - - -* Alt +1- (BPSS2057 to BPSS2076) 
1710a Thailand - - - - +1- (BPSS2057 to BPSS2076) 
1710b Thailand - - - - +1- (BPSS2057 to BPSS2076) 
Pasteur 6068 Vietnam + - - - +1- (BPSS2057 to BPSS2076) 
S13 Singapore + - - - +1- (BPSS2057 to BPSS2076) 
668 Australia 
1655 Australia -* - - - +* 
Strain pairs 1106a & 1106b, and 1710a & 1710b were obtained from two patients who 
each relapsed (from a persistent focus) 3 years after the primary episode of 
melioidosis. `a' denotes primary isolate and `b' denotes relapse isolate. 
- Island absent; + Island present; +/- Island partial present (CDSs missing); -* Island 
absent at the site of insertion but similar region present elsewhere in the gcnome; +* 
Island present and contains extra sequence; NC No contig covering this region 
entirely; Alt Alternative island present at this site (no sequence similarity) 
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Micro-evolutionary diversification was also observed in GI 16, in which an internal 
deletion encompassing CDSs BPSS2057 to BPSS2076 was noted in four unique strains and both 
relapse isolates (Table 3.6). One other strain (1655) contained the complete GI 16 plus additional 
sequence, both within the island and downstream of it. Figure 3.4 shows a comparison of GI 16 
regions in strains K96243,1655 and 1710b (which has the internal deletion). The lack of integrases 
and other mobile genetic element genes, and high variability in gene content, suggests that GI 16 is 
distinct from the other GIs considered here which have structures more typical of mobile genetic 
elements. GI 16 has a mosaic structure consistent with a long history of multiple insertion and 
deletion events. The role of horizontal gene transfer in the evolution of this region is supported by 
anomalous GC composition (Figure 3.4). One of the genes used during PCR to detect GI 16 lies 
within the deleted region (BPSS 2061); 58% of the Thai isolate collection were positive for GI 16 
using primers to this target, compared with a combined result of 76% for both GI 16 gene targets. 
The internal deletion may to account for the discrepancy between these figures. 
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3.6.8 Chapter summary 
This survey of divergent putative GIs in a well defined and clinically 
significant B. pseudomallei population has demonstrated that genetic exchange is 
widespread. The in silico analysis provided evidence that GI 16 may represent a 
composite region rather than a genomic island, and defined a novel GI at the predicted 
insertion site for GI 11. A detailed analysis of the relationship between five GIs and 
both the ability to cause disease and a range of clinical features failed to show an 
association between the two. This study confirms the utility of a range of approaches 
in defining the presence and significance of genomic variation in natural populations 
of B. pseudomallei. Further studies are required to determine the full extent of 
variability in GIs, and their relationship to biological fitness in the environment and to 
disease pathogenesis in the human host. 
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Chapter 4. Results II: Distribution of B. pseudomallei clones in 
relation to geographical location and virulence 
4.1 Chapter content 
MLST has been used to characterize the population structure and diversity of a 
number of important human pathogens, most of which are associated with 
colonization and human-to-human transmission. The free movement of colonized 
individuals between countries and continents leads to worldwide dispersal of bacterial 
genotypes with little geographic structure apparent in many species. In contrast, B. 
pseudomallei is an environmental saprophyte which does not colonize humans or 
other mammals and is not transmitted between them. Inter-continental migration of 
soil microorganisms may potentially arise by long-range wind dispersal, 83 but the 
survival of non-spore forming bacteria may be limited to shorter distances. If so, 
allopatric populations should arise corresponding to distinct endemic genotypes 
("geotypes"). B. pseudomallei provides an ideal species to address the issue of 
migration and its effect on population structure. Furthermore, the ability to assign a 
country or geographic region as the likely source of a deliberately released strain may 
be of value. 
The MLST data currently available for B. pseudomallei has revealed a low 
level of sequence diversity but a relatively large number of multilocus genotypes 
(STs) and limited clustering. 40'90 Analyses of these data, which are mostly restricted to 
isolates from Northern Australia, suggest a high rate of recombination. 97 However, 
there is currently little evidence concerning variation in virulence potential between 
isolates, nor have comparisons been drawn between isolates from different 
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geographical origins to examine the extent of large-scale migration. The objective of 
this study was to use MLST to compare B. pseudomallei isolates recovered from 
disease and from the environment within a single geographical region (northeast 
Thailand), and compare these results to pre-existing data to examine the extent of 
migration between Northern Australia and South East Asia. 
4.2 Bacterial strains 
A total of 266 B. pseudomallei isolates were characterized by MLST. Of these, 
83 were isolated from the environment as described in section 3.2.183 isolates were 
from patients presenting to Sappasithiprasong Hospital in Ubon Ratchathani between 
1989 and 2002, of which 79 were associated with a single clinical syndrome (acute 
suppurative parotitis in children). The remaining 104 invasive isolates were from 
consecutive adult patients diagnosed with melioidosis as described in section 3.4. A 
single isolate was used from each patient. The previously published MLST profiles 
for 158 strains isolated by Prof. Bart Currie, in Northern Australia were downloaded 
from the MLST web site for comparison (httn: //www. mist. net). 8 
4.3 Results and Discussion 
43.1 Diversity of the B. pseudomallei population from northeast Thailand 
The 266 clinical and environmental isolates of B. pseudomallei from Thailand 
characterized by MLST corresponded to 123 STs. The four most commonly recovered 
STs were ST 70 (n=21), ST 167 (n=15), ST 54 (n=12) and ST 58 (n=11). Of the 
remainder, 37 (13.9%) STs were represented by between 2 to 8 isolates, and 82 
(66.7%) of the STs were represented by a single isolate. A greater degree of allelic 
diversity was noted in gmhD and nark than in the other five gene loci; 10 and 13 
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alleles were found in these two loci respectively, whereas only 3 to 6 alleles were 
noted at the other five loci (Table 4.1). Despite the large number of STs detected, 
overall nucleotide sequence diversity was very low; when all unique alleles identified 
in the current study were considered, pairwise comparisons revealed an average of 
only 0.26-0.48% nucleotide divergence over all seven loci (Table 4.1). Estimates of 
synonymous and non-synonymous changes are shown in Table 4.1. 
eBURST was used to identify groups of closely related STs (clonal 
complexes) and to examine the extent to which the data corresponded to a simple 
model of clonal expansion (Figure 4.1). The majority of Thai isolates corresponded to 
a single large clonal complex (CC48) which did not conform to a simple pattern of 
radial expansion; the bootstrap support for the founder of this group was 75% and 
therefore it could not be assigned with a high degree of confidence. Because of the 
relatively high level of diversity at narK and gmhD, many of the single locus variant 
links shown in figure 4.1 correspond to allelic differences at these two loci. A second 
clonal complex (CC70) was also identified which much more closely corresponded to 
a simple radial expansion from a founding genotype, ST70 (bootstrap support 99%). 
In contrast, a much higher degree of variation (a greater proportion of singleton or 
unlinked isolates) was observed for the Australian population (Figure 4.1). 
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Table 4.1. Allele frequency and diversity for 266 Thai isolates of B. pseudomallei 
Locus Number of alleles Average pair-wise 
diversity (%) 
dS/dN 
ace 3 0.26 a 
gltB 5 0.31 a 
gmhD 10 0.47 8.48 
lepA 5 0.33 a 
lipA 4 0.41 a 
nark 13 0.5 14.15 
ndh 6 0.38 3.65 
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4.3.2 Comparisons within the Thai bacterial population 
It is unclear whether strains of B. pseudomallei differ substantially in their 
ability to cause human infection or whether strains are equally likely to cause disease 
in susceptible hosts. This question was addressed by comparing the genotypes of 
isolates from invasive disease and those cultured from soil or water in northeast 
Thailand. 59 STs were identified among the 83 environmental isolates (0.71 STs per 
isolate), and 88 STs among the 183 invasive disease isolates (0.48 STs per isolate). 
The origin (environmental or invasive) of isolates corresponding to the ten most 
commonly observed STs are shown in Table 4.2. Invasive isolates predominated 
within these common STs; 43.7% of all invasive isolates belonged to these 10 STs 
compared to only 25.3% of soil isolates (p<0.0001). There was a significant 
difference in the classification index (CI) between environmental and invasive isolates 
(p<0.001), confirming that genotypes were not distributed randomly between the two 
samples. 
ST70 was the most frequently recovered strain from invasive disease in 
northeast Thailand and was noted 17 times among the 183 disease isolates (9.3%), but 
only four times in the 83 environmental isolates (4.8%). ST70 and a single-locus 
variant (SLV) of ST70 (ST32), have been identified as the cause of melioidosis in 
captive birds, marine mammals and humans in Hong Kong. 90 Other STs also appeared 
to be associated with invasive disease in northeast Thailand (e. g. STs 34,58,167 and 
221), whilst others were under-represented amongst the disease isolates (e. g. STs 54 
and 60). 
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Table 4.2 Sources of B. pseudomallei isolates in the 10 largest MLST clones for 
northeast Thai strains 
ST Invasive isolates (n=183) Soil isolates (n=83) 
ST 70 17 (9.3%) 4 (4.8%) 
ST 167 13(7.1%) 2 (2.4%) 
ST 54 6 (3.3%) 7 (8.5%) 
ST 58 11(6.0%) 0 
ST 34 7(3.8%) 1(1.2%) 
ST 60 4 (2.2%) 4 (4.8%) 
ST 221 7(3.8%) 0 
ST 174 6(3.3%) 0 
ST 33 5(2.7%) 1(1.2%) 
ST 48 4 (2.2%) 2 (2.4%) 
TOTAL 80 (43.7%) 21(25.3%) 
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A classification index proposed by Jolley et a! 122 can also be used to detect 
population differences in allele frequency at each of the MLST loci. 122 This approach 
is likely to be less sensitive in detecting differences between populations than when 
STs are examined, particularly in highly recombinogenic species. When the 
environmental and invasive isolates were compared on a locus-by-locus basis, only 
gmhD (p=0.01) and narK (p=0.05) showed a non-random distribution of alleles. For 
example, gmhD allele 5 was noted 13 times in the 183 invasive isolates, but was 
absent from the 83 environmental strains (p=0.01). Similarly, narK allele 29 was 
noted 7 times in the invasive isolates but was absent from the environmental strains, 
whilst narK allele 2 was noted 20 times in both cases. A relatively high allelic 
diversity (and hence discriminatory power, Table 4.1) may account for why 
differences were only detected in two genes. These alleles may not have any direct 
bearing on virulence potential, but it is possible that they are linked to nearby alleles 
or genomic islands that influence pathogenicity. Such close linkage may also help to 
explain the high level of diversity at these loci. 
To explore further the putative role of bacterial factors in disease, Thai isolates 
were examined from cases associated with acute suppurative parotitis, a single 
defined clinical manifestation with a relatively good prognosis that is rare in northern 
Australia, but is the presenting feature in one third of Thai childhood cases. 7 There 
were 45 STs among the 79 isolates associated with parotitis (0.56 STs per strain) and 
63 STs among the other 104 invasive disease isolates (0.6 STs per strain), indicating 
that isolates causing parotid infection were as diverse as those associated with a range 
of other clinical presentations. There were no significant differences in the CI for STs 
associated with parotid disease and other invasive isolates, but a significant difference 
was found in the distribution of ace alleles (p=0.03). Only three alleles were 
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observed at this locus for all Thai isolates, one of which (allele 4) was rare and 
occurred five times. ace allele 1 was represented in 46/79 (58.2%) of the isolates 
associated with parotitis, and 41/103 (39.8%) of the other invasive isolates. These 
figures are inverted for allele 3, being noted in 31/79 (39.2%) of the parotid isolates 
and 60/103 (58.2%) of the other invasive isolates. 
4.3.3 Comparison between Thai and Australian bacterial populations 
To detect geographical structuring on an inter-continental scale, the 88 STs 
from invasive isolates obtained from Thailand were compared with 96 STs identified 
previously among 158 isolates (mainly associated with disease) from Northern 
Australia. No STs were common to both Thailand and Australia (p<0.0001). This 
complete differentiation was also found when the environmental isolates from 
Thailand were included in the analysis. Comparisons of CI also revealed that allele 
frequencies at each gene were non-randomly distributed between the Thai and 
Australian populations (p=0.0001). There was also a non-random distribution of 
single polymorphic sites; of the 67 polymorphisms present in the Australian data, only 
19 (28.3%) were also present in the Thai data. Individual 2x2 chi squared tests 
revealed highly significant differences in the frequencies of 12 of these 19 
polymorphisms (p<0.0001). Together, these analyses strongly suggest very limited 
gene flow and that the populations of B. pseudomallei have been diverging 
independently in Australia and Thailand. 
To explore further the separation of Australian and Thai isolates, a neighbor- 
joining tree using the concatenated sequences of all seven loci was constructed 
(Figure 4.2). This dendrogram confirmed that the Australian and Thai isolates were 
distinct, with some exceptions. The tree suggested four separate clades; one consisted 
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of Thai isolates alone, another consisted of the majority of Australian isolates, and the 
remaining two clades were mixed, with some evidence for separation of the two 
populations within the clades. The tree was poorly supported by bootstrap scores (not 
shown), hence the topological details are not likely to be indicative of the true 
phylogeny. Despite the poor phylogenetic signal, however, the tree supports a broad 
distinction between the Thai and Australian populations. 
In addition to being distinct on the basis of ST, allele, and polymorphic site 
frequency, there were other notable differences between the Thai and Australian 
samples. A total of 46 different alleles were noted in the 183 invasive Thai isolates, 
whereas 98 distinct alleles were noted in the 158 Australian isolates, confirming the 
suggestion from Figure 4.1 that the Australian population is more diverse. The mean 
heterozygosity per locus (H) was higher for the Australian (0.67 +/- 0.07) than for the 
Thai invasive isolates (0.57 +/- 0.07), although this difference was not significant. 
There was a striking difference in the distribution of allele frequencies between the 
two populations. Of the 98 alleles in the Australian data, 38 (38.7%) were found in 
only one isolate, corresponding to an average of 0.24 unique alleles per isolate. In 
contrast, the number of alleles occurring once in Thai isolates was 9/46 (19.6%), 
corresponding to an average of 0.05 unique alleles per isolate (p= 0.02). Australian 
strains containing one or more unique alleles were no more diverged from each other 
(average pairwise allelic mismatch = 4.7, mean H =0.694 +/- 0.0976) than Australian 
isolates overall (average pairwise allelic mismatch = 4.6; mean H 0.67 +/- 0.07), 
confirming that this difference is not due to the inclusion of a few very distinct 
genotypes in the Australian sample. Alternative possibilities include sampling 
artifacts (the Australian isolates were recovered over a wider geographic area), 
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differences in mutation or recombination rates, or an Australian origin of B. 
pseudomallei in Australia and subsequent spread to South East Asia. 
. ddký 
a 
Figure 4.2 Neighbor-joining tree using the concatenated sequences of all seven 
loci for Thai and Australian isolates (n=266 and n=158, respectively). Isolates 
from Thailand are labeled in red; those from Australia are labeled in blue. The 
majority of Australian isolates appear to belong to a single Glade, although a small 
number of Thai isolates also cluster within this group, possibly reflecting recent 
migration events. A Glade composed entirely of Thai isolates is also apparent. 
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4.3.4 Impact of homologous recombination on diversification of the B. 
pseudomallei population 
The Thai data revealed a small number of alleles at each locus but a relatively 
large number of STs, suggesting that alleles in the population may frequently 
recombine. This is consistent with a previous analysis for the entire MLST dataset 
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The most direct method to evaluate the contribution of recombination is to observe 
the nature of the changes that occur as an ancestral ST diversifies to form SLVs. 
Applying this approach to the ST70 clonal complex showed that the altered alleles in 
9 of the 10 SLVs differed from the allele in ST70 at more than one nucleotide site. 
The low level of sequence diversity would be expected to lead to an underestimate of 
the extent of recombination, as alleles introduced by recombination may frequently 
differ at a single site and could be scored as a point mutation. The fact that only 1/10 
allelic changes among the SLVs involved a single nucleotide change suggests that the 
rate of recombination is very high, relative to mutation. This is supported by an 
examination of the SLVs of the subgroup founders 
82,226 in the major clonal complex, 
where again the great majority of allelic changes can be assigned as the result of 
recombination. 
An examination of phylogenetic congruence based on the method of Feil et 
al., 200180 was also performed. A UPGMA tree was constructed from the allelic 
profiles of all the Thai isolates using the START package. 30 diverse STs were picked 
from this tree, and Maximum Likelihood trees constructed for each gene. For all 42 
pairwise comparisons, the maximum likelihood trees constructed for each gene from 
the Thai dataset were no more similar to the other gene trees than to trees of random 
topology. This total lack of congruence is consistent with high rates of recombination, 
but the paucity of informative sites might limit the ability to detect significant 
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congruence between the loci. The lack of phylogenetic consistency within the Thai 
data contrasts with the broad differentiation between the Thai and Australian data 
evident from Figure 4.2. 
4.4 Chapter summary 
This study has demonstrated the utility of MLST in defining inter-continental 
geographical segregation of an important soil-dwelling pathogen. It is likely that the 
differences between the Australian and Thai populations of B. pseudomallei reflect a 
historical pattern of migration and concomitant genetic drift, possibly in association 
with niche adaptation. 150 The clear distinction between the endemic populations of 
Thailand and Australia shown here has important implications for tracking the source 
of outbreaks or deliberate release. From the study of isolates from Thailand, it was 
apparent that the most common STs are over-represented in the isolate population 
associated with disease. Putative differences in virulence potential in a given ST may 
reflect rapid acquisition and loss of mobile genetic elements, and strain differentiation 
may underlie differences in disease presentation between Thailand and Australia. 
Many cases of melioidosis occur in individuals with risk factors such as diabetes 
mellitus and renal impairment. Further study is required to define whether at-risk 
individuals become infected by the same bacterial population as those without 
definable risk factors, or whether only a subset of strains are able to cause disease in 
the latter group. 
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Chapter 5. Results III: Multilocus sequence typing of Burkholderia 
thailandensis 
5.1 Chapter content 
B. thailandensis is a saprophytic organism that is closely related to B. 
pseudomallei. The genetic and biochemical profiles of the two organisms are similar, 
but B. thailandensis is avirulent with the exception of very rare case reports2.71 MLST 
has been used previously to define a small number of B. thailandensis isolates. The 
purpose of this study was to: 
1. Extend the MLST analysis to a collection of B. thailandensis isolates obtained 
from the environment in Thailand. 
2. Compare the genetic relatedness of B. pseudomallei and B. thailandensis as 
defined by MLST. 
5.2 Bacterial strains 
A total of 92 B. thailandensis isolates were included in this study. Seventy- 
seven isolates were obtained from soil collected from central and northeast Thailand 
between 1990 and 2002, and one isolate was obtained from soil in Seam Reap, 
Cambodia in 2005. The remaining 14 isolates represent strains present in the B. 
pseudomallei MLST database (http: //bpseudomallei. mist. net), details for which are 
shown in Table 5.1. Overall, 86 strains were isolated from Thailand. 
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Table 5.1 Data on 14 B. thailandensis isolates obtained from the MLST database 
Year of 
No. ST Strain original number Country isolation Source Sender 
1 73 82172 34 France 1982 Chicken Dr. Tyrone L. Pitt 
2 74 E27 A3 Thailand 1990 Environment Dr. Andrew J. Simpson 
3 75 VN 534b A5 Vietnam 1997 Environment Dr. Andrew J. Simpson 
4 76 LE1 A16 Laos PDR 1999 Environment Dr. Andrew J. Simpson 
5 77 E125 E125 (ara+) Thailand 1991 Environment Dr. Tyrone L. Pitt 
6 77 E327 A9 Thailand 1998 Environment Dr. Andrew J. Simpson 
7 79 E294 A14 Thailand 1994 Environment Dr. Andrew J. Simpson 
8 80 E111 E111 (ara+) Thailand 1991 Environment Dr. Tyrone L. Pitt 
9 80 E216 E216 (ara+) Thailand 1992 Environment Dr. Tyrone L. Pitt 
10 80 G32 G32 (ara+) Environment Dr. Tyrone L. Pitt 
11 80 E264 ATCC 700388 Thailand 1993 Environment Dr. Jay E. Gee 
12 101 200301589 - USA 2003 Human Dr. Jay E. Gee 
13 345 ' E254 - Thailand 1992 Environment Dr. Jay E. Gee 
14 352 132/02 PHLS E082 Thailand 1990 Rice Field Dr. Tyrone L. Pitt 
102 
5.3 Results 
5.3.1 Allelic distribution and population structure of B. thailandensis 
The existing B. pseudomallei MLST scheme was used to characterize the B. 
thailandensis isolate collection. Twenty STs were defined for the 92 B. thailandensis 
isolates (0.22 ST per isolate), the MLST profiles for which are shown in Appendix 
VI. The three largest clones were ST80, ST345 and ST77, which contained 21 
(22.8%), 16 (17.4%) and 12 (13.0%) isolates, respectively. 
Table 5.2 shows the number of alleles found in the 92 isolates. This ranged 
from 2 (ace) to 6 (lipA). None of the B. thailandensis alleles were present in the B. 
pseudomallei database. 
Table 5.2 Allelic data for B. thailandensis isolates 
Gene Number of alleles allele number 
ace 2 5,6 
gltB 5 5,8,9,10,31 
gmhD 3 9,15,16 
lepA 5 5,8,11,29,30 
lipA 6 7,9,10,11,14,24 
nark 3 7,14,20 
ndh 4 5,8,9,14 
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A UPGMA dendrogram based on allelic data for B. thailandensis is shown in 
Figure 5.1. Two distantly related branches can be observed, with the majority of 
isolates in one cluster, and three STs in a second cluster (ST73, ST101 and ST1000); 
the latter were isolated in France, the US and Cambodia, respectively. The allelic 
data were further represented using eBURST (Figure 5.2). This clearly shows 
separation of ST73, ST101 and ST1000 (which are singletons), from the remainder 
which form a single clonal complex. 
104 
til, CD 
CO 
O 
.r 
.y 
H 
3z 
ti 
ti 
O' 
O 
E 
CL 
O 
L 
"C7 
b 
ßr 
rl 
O 
L. 
bA 
w 
tn,. nnýnnnnn,. aýo öOMKXaýooooo0000000 000cmcoow nmooaoeoaoaoaoooaomm u ro°ODOOOOmoOO01cuýc ne. nn+. ýw. HV. cx r rxnrx rv. cxhmaooooorooooomooaoaoaoaoamcDooooaomoorxxxxh n+ý+ý+. cxxhrxx cxýr, cxxýncxxxn. ý 
01 
1000 41 
S 73 
Figure 5.2 eBURST for 92 B. thailandensis isolates. Numbers represent STs. 
Linking lines between STs represent single locus variants (sharing six of seven 
alleles). The predicted group founder is labeled in blue, while the sub-group founders 
are labeled in yellow. The number of isolates in each ST is proportional to the size of 
the dot. 
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Neighbor joining trees using concatenated sequence of all seven MLST genes 
were constructed in order to compare the relatedness between the population of B. 
thailandensis isolates (Figure 5.3), and between the closely-related species B. 
thailandensis, B. mallei and B. pseudomallei (Figure 5.4). The B. thailandensis tree 
was consistent with eBURST and the UPGMA dendrogram and showed two 
branches, one of which contained ST73,101 and 1000 (Figure 5.3). The tree 
constructed using data for all three species clearly demonstrated that B. thailandensis 
is diverse from B. pseudomallei, while B. mallei clustered with B. pseudomallei. B. 
oklahomensis is genetically distant and is shown as an out-group. A population 
snapshot of all three species using eBURST (Figure 5.5) showed a clonal complex of 
B. thailandensis as a separate group. 
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Figure 5.3 Neighbor-joining tree using concatenated sequence of all 7 loci for B. 
thailandensis isolates. 
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Figure 5.4 Neighbor-joining tree using concatenated sequence of all 7 loci for B. 
thailandensis (A), B. pseudomallei (A) B. mallei (A), B. oklahomensis (A) and 
Burkholderia spp. (A ). Data for the last three were downloaded from the MLST 
database. 
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5.3.2 Diversity of B. thailandensis Thai isolates 
The 86 B. thailandensis isolates from Thailand corresponded to sixteen STs. 
ST 80 was the largest clone (20 isolates; 23.3%) and 6 STs were found only once (ST 
74, ST 356, ST 357, ST 358, ST 359 and ST 363). STs were considered according to 
site of isolation, in which strains were separated into those isolated in the northeast 
(n=67) and central region of Thailand (n=19) (Table 5.3). Six STs were found in both 
regions (pink digit), including the three largest clones (ST 80, ST 345 and ST 77), 
while another 9 STs were found only in northeast Thailand (black digits), and one ST 
(ST 363) was unique to the central region (green digit) (Figure 5.5). 
Some alleles were restricted to northeast Thailand (for example, gitB 8 and 31, 
lepA 29 and 30 and lipA 24), but no alleles were only found in isolates from the 
central region. 
4 
Figure 5.5 eBURST for 86 B. thailandensis isolates. The number of isolates in each 
ST is proportional to the size of the dot. Black digit means isolates found only in 
northeast Thailand, green means ST found only in central Thailand, and pink means 
STs found in both regions. 
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5.3.3 Comparison between Thai isolates of B. thailandensis and B. pseudomallei 
Eighty-six B. thailandensis isolates from Thailand were compared with the 
266 Thai B. pseudomallei isolates described previously. STs per isolate were 
calculated to be 0.46 for B. pseudomallei compared with 0.19 ST per isolate for B. 
thailandensis, indicating a greater diversity for B. pseudomallei. The allelic diversity 
of these two species was defined and compared (Table 5.3). The average pairwise 
diversity and number of polymorphic nucleotide sites for B. thailandensis (0.20% and 
0-3 sites) was considerably lower than that for B. pseudomallei (0.38% and 2-9 sites). 
Estimates of synonymous and non-synonymous changes for both species are shown in 
Table 5.5. The mean heterozygosity per locus (H) within the Thai population of B. 
thailandensis and B. pseudomallei were 0.24 ± 0.08 and 0.58 ± 0.07, respectively. 
These findings imply that the B. pseudomallei population is considerably more 
diverse than the B. thailandensis population. 
A second comparison was made between the 86 B. thailandensis isolates from 
Thailand and the 83 B. pseudomallei isolates obtained from the environment. This 
confirmed the initial observation that B. pseudomallei isolated from the environment 
is more diverse than the saprophytic B. thailandensis. The mean H of the B. 
pseudomallei Thai environmental isolates (0.57 ± 0.06) was similar to the overall Thai 
population (0.58 ± 0.07), with an average pairwise diversity of 0.37% and 0.38%, 
respectively. 
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5.4 Discussion 
This chapter describes the application of the B. pseudomallei MLST scheme to 
the closely related B. thailandensis. Consistent with a previous report, 
90 MLST 
demonstrated a clear genetic distinction between B. thailandensis and B. 
pseudomallei. No alleles were shared between the two species. The B. thailandensis 
population was resolved into two phylogenetic groups, with 3 strains distantly related 
to the remainder of the collection but closely related to each other. These 3 strains 
were from France, the U. S. and Cambodia. The strain from Cambodia was recently 
isolated from soil in Seam Reap, the strain from the U. S. was associated with 
pneumonia and septicaemia following near drowning in a child, and the strain from 
France was isolated from a chicken in whom it was considered a pathogen, thus all 
three can be accurately placed. It is unclear whether more strains would reside in this 
phylogenetic cluster, since the collection tested was strongly biased towards strains 
from Thailand (a function of availability). 
The population structure of B. thailandensis and B. pseudomallei were 
compared. The population of B pseudomallei was more diverse than that for B. 
thailandensis. This was clearly demonstrated using eBURST, and was reflected in the 
higher value of ST per isolate and the greater degree of allelic variation for B. 
pseudomallei. This difference was observed when comparing similar strain numbers 
for each species cultured from the soil in Thailand. The basis for this difference is not 
clear. One explanation is that B. pseudomallei is ancestral to B. thailandensis, with a 
shorter evolutionary time of the latter over which to diverge. This is consistent with 
the finding that B. mallei, which appears to have recently evolved from B. 
pseudomallei, is clonal. An alternative explanation for tighter clustering of B. 
thailandensis is that the population is more constrained by its ecological niche 
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compared with B. pseudomallei which has a range of hosts in addition to existence in 
the environment. It is also possible that the efficiency of recombination is lower in B. 
thailandensis, perhaps due to differences in mechanisms that facilitate horizontal gene 
transfer such as susceptibility to phage and their distribution in the environment. 
Although B. pseudomallei and B. thailandensis are considered to be closely 
related, the finding that no housekeeping gene loci were shared between the two 
species indicates that there is considerable genetic diversity between the two. It is 
possible that the complete lack of shared alleles reflects a specific barrier to genetic 
exchange, the most likely explanation being phage susceptibility. 
Evaluation of Thai isolates cultured from the northeast and central regions of 
Thailand demonstrated that some STs were shared between the two regions, and some 
were unique. The small number of isolates from the central regions combined with the 
relatively high genetic diversity of B. thailandensis indicates that any interpretation 
should be made with caution. Although it is possible that some STs are region 
specific, a larger study would be required before this could be accepted as a robust 
conclusion. 
5.5 Chapter Summary 
This study represents the first evaluation of the population genetic structure of 
B. thailandensis. The population was more clonal than that for B. pseudomallei 
isolated from the same geographical region. The implications of the phylogenctic 
split observed for B. thailandensis is unclear and warrants further study with a larger 
strain collection isolated from a more diverse geographical area. 
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Chapter 6. Concluding comments 
1. MLST was applied to a collection of B. pseudomallei isolated in Thailand, 
and these data were compared to that for a collection of B. pseudomallei isolated in 
Northern Australia. Isolates associated with a single disease entity (parotitis) in 
Thailand were as diverse as Thai isolates associated with a range of clinical 
manifestations. A striking finding was the geographical segregation observed between 
isolates from Thailand and Australia. This is consistent with geographic segregation and 
independent evolution, possibly following land mass separation of Asia from Australia. 
2. An evaluation was conducted of the presence and significance of 5 specific 
genomic islands in a population of B. pseudomallei isolated in Thailand. There was 
considerable variability, both within and between the three clones examined, in the 
presence of the five GIs, suggesting that horizontal gene transfer can rapidly alter the 
gene repertoire of this species. This study also demonstrated the utility of a range of 
approaches in defining the presence and significance of genomic variation in natural 
populations of B. pseudomallei 
3. The B. pseudomallei MLST scheme was applied to a population of B. 
thailandensis isolates cultured from the environment in Thailand, and existing MLST 
data was downloaded from the mist database. This demonstrated that B. thailandensis 
fell into two phylogenetically distinct clusters. The smaller cluster contained isolates 
from outside of Thailand, and it is possible that this clustering represents geographical 
variation in population although conclusions are limited by the number of isolates 
obtained from outside of Thailand. B. thailandensis was more clonally restricted. The 
basis and effects of this require further study. 
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